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ABSTRACT
Mouse brain choline-0-acetyltransferase (E.C. 2.3.1.6)
(ChAT) activity was studied in vitro using a lOOmM sodium
phosphate buffer (pH 7.4) wash of a crude vesicular fraction containing solubilized ChAT and a washed crude vesicular fraction containing membrane bound ChAT. Both the solubilized and membrane bound forms of ChAT can acetylate
choline linearly for 30 minutes.

High concentrations of

acetylcholine (Ach) can inhibit solubilized ChAT to a
greater degree than the membrane bound enzyme form.

FoFtY

percent of the Ach synthesized by membrane bound ChAT survives hydrolysis in the presence of an excess of acetylcholinesterase (AchE), whereas none of the Ach synthesized
by the solubilized enzyme form does.

4-(l-naphthylvinyl)-

pyridine inhibits solubilized ChAT more than the membrane
bound form, either in vivo or in vitro, and reduces mouse
locomotor activity by 80-90% . for 3 hours. Solubilized ChAT
is totally sodium dependent whereas the membrane bound
form is only partially sodium dependent.

Membrane bound

ChAT has ·both a high (Km 3.2 uM) and a low affinity
(Km=0.48 mM) Michaelis constants as a function of added choline when velocity values are not corrected for acetylation
of endogenous choline.

Upon correction, only a low affinity

Michaelis constant (Km=0.47 mM)

ii
"

is obtained for the membrane

bound enzyme form, similar to that of solubilized ChAT
(Km=.17 mM).

The choline analogues triethylcholine and

homocholine are acetylated preferentially by membrane
bound ChAT.

The results suggest the ex i s tence of a me m-

brane bound form of ChAT in mouse brain which is able to
synthesize Ach.

iii
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I NTRODUCTi m
Acetylcholine is a uutative transmitter in the central
nervous system, and is beleived to be stored in two subcellular pools in the central ch olinergic nerve ending, the
cytoplasm and the synaptic vesicles (DeRobertis et al, 1963;
Whittaker et al, 1964; see review by Hebb, 1972). The majoroty of the enzyme which synthesizes acetylcholine( Ach)
from choline and acetyl CoA, choline-o-acetyltransferase
(E.C . 2. 3.1.6 . ) (ChAT) is beleived to exist freely in the
cytoplasm of the nerve ending under physiological conditions
(Fonnum , 1966; 1967; 1968; 1973; 1975) .

The Ach stored in

synaptic vesicles is beleived to originate in the cytoplasm
~Fotihum~l9?3; ~1815} .

In the classical model of central

ch olinergic neurotransmission, Ach is synthesized in the
cytoplasm and transferred to vesicles, where it is released
during depolarization .

Eowever, t h e transfer of cyt oplasmic

Achin to vesicles ( Marchbanks, 19 68 ; Katz et al, 1973;
Carroll and Nelson, 1978) or synaptic vesicle ghosts 9Susz kiw, 1976) above diffusion levels has not been demonstrated.
Recently, it has been reported that some ChAT is associated
with synaptic vesicles ( Hattori et al, 1976; Feigenson and
Barrnett, 1977), although the relative physiological roles
of the enzyme in this location and t hat present in the cytoplasm remain to be established.
Several investigators have suggested that a form of
ChAT may be associated with the presynaptic neuronal membrane
(Guyenet et al, 1973; Barker and Mittag , 1975; Eaubrich and

I~
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Chippendale, 1977), and may be responsible for the efficient
acetylation of choline accumulated by the high affinity
choline transport system, whish is beleived to be associated
with cholinergic nerve endings, in contrast to the low affinity choline transport process (Kuhar et al, 1973; 1975~.
The high affinity transport process has a Kt value for choline
in the micromolar range (Yamamura and Synder, 1972; 1973;
.3arker and Mittag, 1975; Carroll and Buterbaugh, 1975a; 1975b;
Carroll and Gol berg, 1975) and consequently, ChAT may be
associated with membranes and have a lower Km for choline
than solubilized, or cytoplasmic, ChAT, the most widely
studied form of the enzyme, which has been reported to have
Km values for choline in the millimolar range (see Table 1) .
Furthermore , evidence concerning the substrate specificity
of ChAT indicates that a form of ChAT exists in nerve endings
whi ch is able to efficiently acetylate homocholine , a choline
analogue which is not acetylated by the solubilized form of
ChAT (Burgen et al , 1956; Dauterman and Mehrotra, 1963;
Currier and Maunter, 1974; Collier et al, 1977), even at
micromolar concentrations (Collier et al, 1977).
One group of investigators has reported that 4- (1 - naphthylvinyl)pyridine (4 - NVP), a potent in vitro inhibitor of solubil~zed

ChAT (Smith et al, 1967 ; Allen et al, 1970; Caval-

lito et al, 1970; Baker and Gibson, 1971; 1972;

Goldberg~

al, 1971; Krell and Goliberg, 1975)is only able to maximally
inhibit nerve ending ChAT in vivo by 65% without affecting
intracellular Ach levels (Krell and Goldberg, 1975) .

-3-

One possible exulanation for these results is that ChATiis
in excess in the nerve ending (Schuberth et al, 1970; Carssn
et al, 1972; Ross et al, 1971; Hebb, 1972; Glick et al , 1973;
Saelens et al, 1973; Jenden et al, 1974; Krell and Goldberg,
1975).

An Excess of ChAT in the nerve ending could account

for choline acetylation from high affinitj choline transport
concentrations and a 65q-b nerve ending ChAT inhib ition without an affect on Ach levels.It should be noted that nerve
end ing ChAT was inhibited by 65% at dosag e levels of either
200 or 400mg/ kg 4-NVP .

Since complete inhibition of nerve

enging ChAT by 4-NVP could not be reached, and the choline
analogue homocholine could be acetylated by intact synaptosomes but not the solubilized preparation of nerve @nding
ChAT, other possible exppanations may be that other forms
of ChAT are present in vivo which are not inhibited by 4- NVP
and are able to mamntain brain Ach levels, and are also less
substrate snecific thansolubilized ChAT, as has been suggested by Collier et al (1977), or that compartments exist
in the nerve ending which are not identically exposed to the
inhibitor or choline

analogue~

and enough ChAT is

RX~NXEM

either protected from 4-NVP inhibition to maintain intracellular Ach levels, or enough ChAT is exposed to choline
analogues to allow acetylation.

The existence of such com-

partments has been suggested by studies of nerve endings
and

synap~osomes

employing non-osmicating fixation techniques

which have revealed a. membranous presynaptic network (Bloom
and Aghajanien, 1966; Jones, 1969; 1970) and a presynaptic
vesicular grid (Jones, 1972).

-4The purpose of t h is research was to determine if a nonsoluble or membrane bound for m of ChAT exists in mouse brain
n erve endings, and to compare some of mt s properti es wit h
t h os e of the solubilized enzyme form.
Th e enzyme forms used i n t his study

~ er e

prepared fro m

minces offforebrain of male (CF-1) albino mice, which were
incubated in a 35mMK+Krebs bicarbonate buffer medium 9pH7.4).
This incubation procedure is beleived to simulate physiological stimulation (Salehmoghaddam and Collier, 1976; earroll
and Goldberg , 1976) and reduce intracellular Ach levels,
which maybe inhibitory to the synthesis of Ach ( Kai ta and
Goldberg , 1969; Glover and Potter, 1971;

~arris

et al, 1978 ).

Subcellular fractions were prepared according to the meth od
of Gray and Whittaker (1962), as modified by Collier et al
(1972) and

Sale~oghaddam

and Collier (197 6 ).

somal fraction was hypo- osmotically

sho~ked

The stnapto-

by an approxi-

mate 10 fold excess of glass distilled water (pH 4.0) ,
and hi gh ionic strength washes (100mM sodium phosphate buffer,
pH 7 . 4 , ionic strength 160mM) of the crude vesicular fraction ,
obtained after high speed centrifugation, solubilized that
ChAT ionically bound to membranes (Fonnum,19 66; 1967; 1968;
1975} Hebb, 1972) .

The washed crude vesicular fraction , con-

taining nonionically membrane bound ChAT, was then suspended
in a t hrue fold excess of glass distilled water ( pH 4.0) .
Th e enzym e activities were determined u sing t h e buffer sub strate described by McCamenband 5unt (1 965), containing 35 0uM
ac et yl ( 14c ) CoA. Af ter incubation at 39 C C:ebb et al, 1975 )
i n t h e nrescen ce of add ed ch oline an d an aliquot of t h e sub cel±

-5lular fraction being studied, ( 14 c) Ach is then senarated
from acetyl ( 14 c) CoA by liquid cation exchange with sodium
tetraphenyl boron in a 3-heptanone (5mg/ml) at an approxi mate 7 fold excess , according to the method pf Fonnum (1969).
Aliquots of the 3-heptanone layer were counted in a toluene
based scintillation fluid, and t h e amount of ( 14 c) Ach produced was calculated from the known specific activity of
acetyl ( 14 c) CoA. Protein determinations were done according to the method of Lowry et al (1951).
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LITERATURE REVISW

Recently, the involvment of the central cholinergi c system in mental disorders has been discussed (Davies et al, 1978).
Cholinergic mechanisms may play a role in Huntington's disease and tardive dyskinesia, since the use of choline chloride
may improve the involuntary movements involved in these diseases
(Davies et al, 1976).

Choline treatment can also be associated

with an improvement in the symptoms of schizophrenics (see
Davies et al, 1978), and anticholinergic drugs can aggravate
schmzophrnia.

Cho~inergic

underactivity may be involved in

mania (Janowsky et al, 1972; Davies et al, 1975) an d euph oric
manics less manic symptoms following cholinornimetic drug s, although irritable manics are not affected (Davies et al, 1978).
The administration of acetylcholinesteraseE(AchE) inhibitors
has been reported to develop depression, and/or impaired memor~

and concentrationx (Rowntree et al, 1950; Gershon and

Shaw, 1961; Bower et al, 1964; Medestein et al, 1973; Davies
et al, 1977).
Choline-o-acetyltransferase (E.C.2.3.1.6.) (ChAT) catalyzes the synthesis of acetylcholine(Ach) in the following
reversible reaction:
+

+

(CH3 ) 3NcH2cH 20H + CoAS-ParCH3
choline
acetylCoA

=

( CH3 ) 31TCH 2CH 20$CH3

+

CoA

acetylcholine

ChAT was first discovered in tissue containing cholinergic nerve endings by Nachrnansohn and Machado (1943), but it
has been shown that the enzyme is pDEsent in nervous tissue
rather than the tissue innervated (Bannister and Scrase, 1950;
Collier and Katz, 1971; Hebb et al, 1964; Potter , 1970Q ••

-7ChAT is also found in the non-innervated placenta of higher
primates (man and Rhesus monkey) although its functional role
has not been determined (Hebb and Ratkovic, 1962; Morris 1966;
Aorris et al, 1971; Rama Sastry and Eendersen, 1972; White
and Wu, 1973; Rama Sastry et al, 1976; Welch, 1976).

ChAT

is found in the bacterium, Lactobacillus Plantarum (Stevenson and Rowatt, 1947; White and Cavallito, 1970), and in the
gill plates of rtrtilus edulis ( Bulbring et al, 1953).
In nervous tissue, the distribution of the enzyme and
ChAT activity is similar to the distribution of Ach and cholinergic nerves (?eldberg, 1945; nebb and ·1orris, 1969; Ka.sa,
1971).

The concentration and total amount of enzyme in

human brain increases during fetal development (Bull et al,
1970); however, the level of ChAT activity in adult brain is
less than the ChAT activity in nine year old human bra.in
(Bull et al, 1970) .
ChAT is synthesized within the cell bodies of cholinergic neurons and transported to the nerve terminal ( Hebb et al,
1964) by fast or intermediate axpplasmic transport (Fonnum,
1973) and its half life has been reported in the range of 1221 days ( Fonnum , 1973; Oesch, 1974).

Neuronal activity may

induce new ChAT synthesis ( Oe ch , 1974).

Only 10% of the tot-

al amount of ChAT present in ventral spinal neyrons is located
in the cell body (Weil et al, 1977).
Under phsiological conditions, it is beleived t hat t h e
majority of the enzyme is localized freely in the cytoplasm
of the nerve ending ( Fonnum , 1966; 1987; 1968; 1970; 1975 )
and not associated with synaptic vesicles or other membrane
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organelles in the presynaptic neuron ( Whittaker et al, 1964\).
Vesicles containing Ach have been discovered in the nerve ending (De Robertis et al, 1963; Gray and Whittak er, 1962; Whittaker et al, 1964; Whittaker and Sheridan, 1965) and release
of Ach from these vesicles has been postulated in accordance
with the quantal hypothesis ( Fatt and Katz, 1952).

This hypo-

thesis states that Ach, and other neurotransmitters within
the nerve terminal, are released in discrete units, and elicit
miniature endplate potentials (m.e.p.p. 's) of equal magnitude
in the abscence of depolarization and a nerve impulse stimulates the nerve terminal to release quanta simultaneously,
causing an increase in the frequency of m.e.p.p. 's, resulting
in an end plate potential (e.p.p.).
The subcellular distribution of the enzyme is kno\.Vn to
be be dependent and influenced by the conditions of synaptosomal hypo-osmotic shock (Fonnum, 1966; 1967; McCamen et al,
1965; Tucek ,1966).

For all species, however , an increase in

the ionic strengt h at physiological pH solubilizes ChAT from
membranes, and a decrease in the ionic strength facilitates
binding of the enzyme to membranes (Fonnum, 1966; 1967; 1968;
Potter et al, 1968).

The binding of ChAT to membranes is be-

leived to result from an ionic attraction between a positively
charged enzyme and a negatively charged membrane (Fonnum, 1968 ).
The isoelectric point and surface charge of ChAT differ in
pigeon and guinea pig brain ( Fonnum, 1968; Malthe-Sorensson
and Fonnum , 1972), perhaps explaining the species variability
observed in subcellular distribution studies.

-9-

Two different forms of partially purified Ch.AT have b een identified in human neostriatal tissue and can be distinguished by
elution patterns from phosphocellulose columns , stabi lity,
and antibody producing cauacity (Singh et al, 1975).

ChA

~mayy

also exist in at least two forms in rat and cat brain (maltheSorensson, 1971; 1972) and in three forms in rat hippocampus,
caudate nucleus, and sciatic nerve, indicating that in some
species, closely related molecular forms of Ch.AT exist and
these forms may differ in their membrane affinity.
The molecular weight of purified ChAT has been reported
to be from 35,000 daltons (White and Cavallito, 1970) to

1, 500,000 daltons (Chao and Wolfgram, 1974) .

Th e higher mol-

ecular weight forms of Ch.AT may have been produced by treat ment of the

ini~ial

extract with ammonium sulfate, since Cha.a

. and Wolfgram (1974) have reported t hat this treatment may
cause aggregation of Ch.AT.

It has been shown that storage

for 2 to 3 weeks at - 20 C causes disappearance of the hi gh er
mo lecular wei ght forms ( Banns, 1976).

The apparent ammonium

sulfate effect may be partially responsible for the multiple
forms of Ch.AT found in rat and cat brains by isoelectric
focusing techniques (.,1al the-Sorensson and Fonnum, 1972) and
the multiple forms found in human brain and sciatic nerve
( White and Wu, 1973), since both groups of investgators used
ammonium sulfate in their purification procedures .

Evidence

for isozymes of the 65,000 dalton form of Ch.AT may be limited
to the asymmetrical peak of enzyme

acti~ity

obtained by Glover

and Fatter (1971) . In contrast, the 65,000 dalton form of
Ch.AT obtained by Chao and Wolfgram (1974) without the use of

-10-

ammonium sulfate appeared to be of only one molecular species
o f ChAT .

In a later publication, Chao (1976) purified ChAT

and found its molecular wieght to be 87,000 to 89,000 daltons
and to have 6 identical subunits, although these are resistant
to senaration by a variety of techniques (Weber and Osborn,
1969; Swank and Munkres, 1971; Peterson , 1972; Moss and Rosen-

blum, 1972; Davies and Stark, 1970; Chao and ':/olfgram, 1973).
The amino acid sequence of the enzyme is known (Chao, 1976).
It should be noted that

15-30~

of the total nerve ending

ChAT remains attached to membranes (Hebb, 1972) and is beleived to be nonionically membrane bound ( Kucenski et al, 1975).
The cytochemical studies of Hattori et al (1976) and Feigenson
and Barrnett (1977) have suggested that at leas±

some syna.p-

tosomal ChAT adheres to vesicles, and other investigations
indicate that ChAT may be within vesicles (Hattori et al, 1978)
and associated with the membrane of the presynaptic nerve
ending (Barker and Ai ttag , 1975; Haubrich and Chippendale, 1977).

THE

:1EC HA~

IS 'I OF SOLUBILIZED Cr.AT

The generally accepted mechanism for

solu~ilized

Ch.Am is

the Theorell- Chance mechanism (Cleland, 1963) based on kinetic
studies ( }lhite and Cavallito, 1970; f orris et al, 1971; Eendersen
1

and Ra.ma Sastry , 1972; White and Wu, 1973; Emson et al, 1974),
which predicts that jhe formation of an intermediate enzymea.cetyl Co.A-choline complex is immediately followed by product
formation, thms permitting only a low concentration of intermediate to exist (Currier and Mautner, 197 4; Lal the-Sorensson,
1976).

Inhibition studies suggest the involvements of both a

-11-

thiol group (?otter et al , 1968 ; Mannervik and Sorbo, 1970;
Roskowski, 1973) and a histidine residue

('~Thi te

and Cavalli to,

1970; Currier and .·1autner, 1974; Roskowski, 1974).

Thiol re-

agents such as p-chloromercuribenzoate, N-ethyl maleimide,
iodoacetate , and 5 , 5'dithiobis-(2-nitrobenzoate

(D:I'.~JTB )

pear to inhibit the enzyme, and acetyl CoA protects the

apenzy~e

from inhibition (Malthe- Sorensson, 1976; Berman- Reisburg, 1957;
Potter et al , 1968 ; Mannervik and Sorbo, 1970; Roskowski, 1974) .
Eowever, the possibility exists that the action of the thiol
reagents may be more peripheral in nature , causing conformational c anges and denaturation (White and Cavallito, 1970;
Mannervik and Sorbo, 1970) .

Other complications include species

differences in the sensitivity of ChAT to such reagents (Glazer,
1970; White and Cavallito, 1970).
The essential involvement of a histidine residue has been
implicated by Malthe- Sorensson (1976) by incubation of the
:purified enzyme with diethylpyrocarbonate , and the formation
of N- cabethoxy histidine residues was measured .

Imidazole res-

idues have also been implied to be related to Ach synthesis
by Hebb et al, (1975) and it can catalyze the formation of
Ach nonenzymatically ( Burt and Silver , 1973; Aquilonius , 1976) .
Imidazole has also been shown to activatew ChAT, somEtimes by
80-100% ( White and Cavallito, 1970; Hebb et al, 1975) .
Active ChAT has been immobilized on mercurisepharose gels
(Malthe- Sorensson , 1976).

The validity of this technique to

study an enzymatic reaction may be questioned since it has
beenshown that the immobmliza ion of enzymes to dmfferent types
of supports changes their affinities for substrates, their pH
optimum (Golstein et al, 1964; Homby et al, 1968) and their

-12-

reaction kinetics (Kasche et al, 1971; Goldman et al, 1971).
However, the number and type of different residues involved
in the reaction meahanism are not beleived to change.

The

binding of ChAT to mercurisepharose gels is beleived to occurr
at the thiol group in the active site, since preincubation of
the enzyme in acetyl CoA inhibited binding to the g el .

The

bound emzyme is able to form Ach , indicating a nonessential
thiol group (Mal the-Sorensson, 1976).
Further evidence implicating a functional histidine residue is provided by the fact that diethylcarbonate prevent s
the immobilized enzyme to form ACH ( Malthe-Sorensson, 1976).
In such a reaction meahanism, the rate limijing step would
be the nucleophilic attack of histidine on acetylCoA with a
fast reaction with choline (Bruice, 1959).
In a more recent study, it has been suggested that choline
and acetyl CoA bind in a random, not ordered, mechanism , since
dead end complexes of enzyme-acetyl CoA Ach and enzyme-cholineCoA were present , and the dossociation of CoA appeared rate
limiting in the forward reaction ( Hersh and Peet,1978) .
The effect of sodium chloride on the synthesis of Ach in
rat striated synaptosomes has been investigated ( Guyenet et al,
1973), and decreased sodium concentrations are associated with
decreased synthesis of Ach from glucose , but this inhibibi:on
can b:e reversed by the addition of choline, indicating that
the reduction of Ach synthesis is not due to impaired rrmtabolic
activity (Guyenet et al, 1973).
Rossier et al (1977) have found that the chloride anion
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activates the Vmax of unpurified solubilized

ChA~

from rat

brain more effectively than several other anions, wheras the
cation only affects the Vmax slightly. These investigators
and others (Glover and Potter, 1971) have reported t hat
purification procedures can affect the respons e of the enzyme
to salts, and the enzyme's Km for choline and acetylCoA.
Hersh et al, (1978) using a highly purified preparation of
solubilized ChAT, has found that its activity is regulated by
ionic strength, and divalent cations such as Mg+ 2 and ca+ 2
inhibit the enzyme already activated by Na+•

In this study,

the total anionic strength was able to influence ChAT 's a.ct-

-

ivity, and no selectivity for Cl- was found.
Therefore , it appears that solubilized ChAT is able to
catalyze the synthesis of Ach through an a.cetyl transfer by
a histidine residue in the active site, arid an apparently
nonessential thiol is also in or near the active site (Currier
and Mautner, 1974; Malthe-Sorensson, 1976).

Furthermore, at

physiological ionic strength, unpurified ChAT is activated by
both sodium (Guyenet et al, 1973) and chloride inns +~ossier
et al, 1977), suggesting that either or both may be necessary
for the regulation and maintenance of ChAT activity( Hersh et
al, 1978)
Kinetic studies, in addition to providing information
about the mechanism of ChAT, also provide

informatio~

con-

cerning the concentrations of the substrates likely to be required for the synthesis of Ach in living tissue.
inhib ition studies can
may b e regulated.

al~o

Product

reveal mechanisms by which ChAT

Km values for choline and acetyl CoA are
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consistent across several species (see 1ab le 1).

It sh ould

b e noted that Kucensk i et al (1975) has describ ed a membrane
b ound form of ChAT in rat brain , and found it to be kinetically
similar to solubilized ChAT .
Alth ough t h e mechanism of t he r eaction has not 8een elucidated with availa8le kinetic evid en ce, it is gen erally agreed
t nat a sequential mechanism exists and b oth substrates mu st
interact with the enzyme before any products are releas ed ,
(see review by Hebb, 1972).

The products, Ach and CoA, have

both been found to be inhibitor1 to Ach synthesis ( FBtter et
al, 1968 ; Kaita and Goldberg, 1969; Morris and Hebb, 1970;
Morris et al, 1971; Glover and Potter, 1971; tlhi te and du,
1

1

1973), and CoA has a Ki similar to the ~ of acetyl CoA.

It

s h ould be noted that although high concentrations of Ach can
be inhibitory to Ach production, the maximum ChAT i nhibition
attained by Ach is 50: 6 ( Potter et al, 1968; Kaita and Go ldberg ,
1

1969; Gl over and Potter, 1971).

I 3HI BITORS OF

Ch~.\T

To date, no inhibitor of ChA_ has been found that uroduces effects on ch olinergic transmission due to a direct
inhibition of ChAT.

In vitro inhibitors of ChAT include styryl-

pyridine analogues such as 4-(1-naphthylvinyl)pyridine (4- V? ),
which a.re able to inhibit AchE to varying degrees (Smith et
al, 1967; Cavallito et al, 1970; Goldberg et al, 1971; Krell
and Goldberg, 1975), halogenated analogues of Ach (Chaseaand
Tubbs , 1966; Morris and Grewaal, 19 69; 1971), a.croyloyl choline
( Malthe-Sortnsson, 1974), acetylsecohemicholinium-3 (Domino
et al, 1973;
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a.nd 3-bromoacetonyl- trimethylammonium bromide., or bromoketone
(Persson et al, 1967), although this last inhibitor has been
shown to inhibit an enzyme capable of hydrolyzing a.cetylCoA
in Purkinje cells of the cerebellum and sensory root ganglion
cells ( Kasa et al, 1970) .
Of the styrylpJrridine analogues, Hebb (1972) has suggested
that 4- 3VP would inhibit ChAT specifically and not have significant action on cholinesterases.

Goldberg et al (1971)

has found that 4- VP inhibits mouse brain ChAT in adose dependent manner in the range of 25 to 100mg/kg in vivo, but maxi mum inhibition (*#83%) occurred 4 hours after a 200mg/kg i . p.
injection .

Signs of depression and ataxia were

a.t this dose.

obs~rved

24 hours after a. 200mg/kg dose, no inhibition

of ChAT was detectable .

4-NVP was able to inhibit the hexa-

barbitone-metabolizing enzyme system more effectively than
ChAT in vitro, and the sleep time of mice was potentia.ted 3.5
fold by an i . p. dose of 25mg/kg of 4- VF when given 30 minutes
before barbituate treatment .
at a 4 h ours was

337 mg/kg . Th ~se

Th e acute i.p. LD50 for 4-NVP
investigations have also found

that 4- NVP potentiated the behavoral effects of the AChE inhibitor physostigmine .
to administer

4- N V~

Repeated attempt by several investigators
in vivo and reduce the levels of brain

Ach levels have been unsuccessful ( Cars on, et al, 1972; Glick
et al, 1973; Eaubrich et al, 1974; Krel l and Goldberg, 1975) .
One report indicates that i.p. administration of 200 or 400
mg/kg of 4-J VP to mice inhibits brain ChAT activity 65C.1a without altering brain levels of Ach (Krell and Goldberg ,

1975~.
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Furth ermore, Feigenson and Barrnett (1977) have renorted in
vitro with a partially purified mouse brain ChAT preparation
65 ~

inhibition was attained with eith er a 5or 10 uM concen-

tration of 4-NVP.

Also, Aquilonius et al (1970) was unable

to demonstrate any effect of 4-NVP on neuromuscular transmission
in the cat that would be related to ChAT inhibition.

These

results were interpreted to indicate that brain ChAT activuty
is not rate limiying in the formation of Ac h by the nerve
ending.

An alternative possibility is that the majority of

brain Ach may be synthrsized by ChAT which is in a subcellular
location that is inaccessible to the inhibitor.
The in vivo administration of bromoacetylcholine , an effective
in vitro unhibitor of ChAT ( Morris and Grewa.al , 1969; 1971),
has been unsuccessful in reducing rat brain Ach levels, even
after 93% of the AchE had been inhibited, thus inhibiting the
hydrolysis of the inhibitor, bromoacetylch oline ($peth et al,
1976).

No change in brain Ach levels were found, suggesting

that either 7% of t h e normal AchE activity was sufficient to
hydrolyze the inbibitor, or that spontaneous hydrolysis of t h e
inhibitor occurred, since Hebb (1972) had found that at neutral
pH, these analogues are unstable.

CEOLINE
Free choline does not appear to be highly concentrated in
cholinergic nerve endings ( Mann and Eebb, 1977), its cone entration in rat brain tissue being approxi mately 33uM (Stavinoha
and Weintraub, 1974), about one tenth the Km for choline of
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solubilized ChAT .

Therefore, changes in the intracellular

choline concentration would be expected to affect Ach
sjnthesis.

The rate of release of Ach from the superior

cervical gangli on of cat (Collier and Katz, 1974), rat
(Sacchi et al, 1978), and mouse brain minc es (Carroll
and Goldberg , 1975) is enhanced when choline is present
int perfusing or bathing medium.

Choline induces an in-

crease in the concentration of Ach in the hippocampus, a
brain reqion rich in cholinergic nerve endings but not
cell bodies , and denervation of rat adrenal gland abolishes
this increase in Ach fomlowing choline administration

( ~au

brich and Ghippenadale, 1977).
Sources of free choline in the brain include dee novo
synthesis , an extremely slow process if present at all(Fr eeman and Jenden , 1976), phospholipid degra!!a.tion, since
choline phospholipids can be symthesized in the brain or
transported to the brain via the blood , suggesting that
these compounds ca.n be ca.tabolized to form free choline
(Ansee and Spanner , 1968; 1971; 1975;

I llin~#orth

and

Portman , 1972; Hoelzl and Franck , 1973; Orlando et al, 1975),
a base excange reaction in which choline may enter or be
released from phosphatidyl choline directly (Abdel-Latif
and Smith , 1972; Brammer and Sheltawg, 1975; Dahlberg an d
Schuberth , 1977), and plasma choline which crosses the bl
blood brain barrier, either by a saturatable uptake system
(Sparf, 1973;Cornfed et a.l, 1977) or by diffusion (::5'ree~an

et al, 1975).

An other so'llllI'ce of choline in the brain

is that choline produced by the hydrolysis of Ach b y AchE.
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The concentration of choline in the synaptic cleft produced
in this way has been estimated to be in t he millimolar range
(Whittak er, 1963).
In light of the several sources of choline present in
brain, it should be noted that the majority of releaseable Ach
is derved frm extracellular choline (Gardiner, 1961; Browning
and Schulman, 1968; Carroll and Goldberg, 1975), and that newly synthesized Ach is preferentialy released over preformed Ach
(see review by !:ebb , 1972).

li owever, it has been shown that

brain tissue can synthesize relatively large amounts of Ach
when incubated in the abscence of choline (Browning and Schulman,
1968; Collier et al, 1972) indicating that both endog enous and
exogenous stores of choline can be used for Ach synthesis .
:SX:tracellular choline is transported into synaptosomes
(Ya.mamura and Synder, 1972; 1973; Barker and
Carroll and

Buterbau~h,

r.~ ittag,

1975;

1975) and minces (Carroml and Goldberg ,

1975) pEe~ared from brain by two distinct uptake mechanisms, a
high affinity system with a Kt of 0 . 5 to 5uM and a low affinity
system with a KT of 50- 100uJV: .
in~o

Most of the choline transp orted

synaptosomes by high affinity transport is beleived to be

converted to Ach (3arker and Mittag , 1975) .
The high affinity choline transport sy stem is beleived to
be localized specifically in cholinergic nerve terminals in
brain (Kuhar et al, 1973; 1975) since denervation studies have
shown that depletion of cholinergic nerve terminals is accompanied
by a selective loss of high affinity choline transport
~xx~x+xx~~l¥XM~~Xal]{~XX~M~+xxE7ll

t~~j~M~X

Sodium and chloride ions are

~tl~f~e~ to be necessary for high affinity transport (Guy enet

9
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et al, 1973; Ha ga and Noda, 1973; Simon and Kuhar, 197 6 ; Kuhar
1978), as is a source of energy , since t he metab olic inh i bit or
2,4-dinitrophenol inhibits high affinity transport by 25S6
( Dowdall and Simon, 1973;

~amamura

and Synder, 1973; Simon and

Kuhar , 1976 ), and a sodium-potassmum ATFase may be involved
(chultz and . Curran, 1970).
Some attempt s to couple h i gh affinit y choline transport
and ch oline acetylation have suggested t hat ch oline mu st cross
t h e high a.ffini t y transport sy stem to be ac:ety la.ted (Lefresne
et al, 1975), while others (Barker and

r~ i ttag ,

1975; Suszkiw

and Pilar, 1976; Jape and Jenden, 1977) have fevered a kinetic
coupling between transport and enzym e (controll ed by the i ntracellular choline concentration availab le for Ach synt hes is).
Atterwill and Prince (1978 ) have sugg ested that one of the molecular forms of ChAT, which is present in adult rat bra.in but n ot
in 7 day old brain, may be responsible for t he coupp ling of high
affinity ch oline uptake and choline ac ety lation .

I-i owev er , ex-

periments with cat superior cervical ganglion suggest a la.ck of
coupling (Collier and Ilson, 1977; Colli r et al, 197 7) and
in bra.in tissue (Barker, 1978).
In depolarized in vitro preparations, hi gh affinity tra.ns n ont
is reduced or lost, and choline taken up by the low affinity
system is acetyla.ted effeciently (8arroll and Goldberg, 1975;
Murrin and Kuhar, 197 6 ; Vaca and Bea.c h , 1977).

Eowever, direct elec

trical stimulation of cholinergic tracts and administration of
convulsant drugs in vivo have been shown to increase t he Vmax
of high affinity ch oline transport (Atweh, et al, 1975; Simon
and Kuhar, 1975; Jenden et al, 197 6 ; Simon et al, 197 6).
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In contrast to the high affinity choline transport system, low affinity transport is not beleived to be specific to
cholinergic nerve endings (Diamond and Kennedy, 19 69 ; Ya.ma.mura
and Synder, 1973) and may supplj choline for pkosph olipid
synthesis.
Pa.rental administration of choline may result in an increase in plasma and brain choline levels and barin Ach levels
( Haubrich et al, 1974; 1975 ; Cohen and Wurtman, 1975).
results may suggest that the low affinity choline

These

u~take

is

involved in Ach formation, and the elevajion of plasma choline
may promote Ach synthesis at sites remote from choli ergic
terminals where only the low affinity transport system is
operating.

However, carnitine acetyltransferase, an enzyme

present in brain tissue, may be able to acetylate chol ne
(White and Wu , 1973; Schrier et al, 1974), although Bradshaw
and Hemsworth (1976) have shown that carnitine is a.cewtylated
200 times as well as choline by carnitine acetyltransferase.

CHOLI JE ANALOGUES
ChAT is not absolutely specific for its physiological
substrate, choline (Hemsworth and Smith, 1970; Currier and
:autner, 1974 ; 13arker and Mittag, 1975; Mann and Hebb, 1975;
Collier et al, 1977; Ilson et al, 1977).
It has been assumed that the inhibition of Ach synth esis
in synaptosomes by hemicho linium-3 (EC-3) is due to the inh ibition of t h e choline uptake mechanism (Diamond and Kennedy ,
1969; Fonnum, 1973).

It has b een argu ed, h oever, tthat the

reversal of t h is inh bition by the addition of ch oline occurrs
too slowly to b e accounted for by a raec hanism on t h e outs ide
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of the presynaptic membrane (such as a transport carrier),
a.""1.d t hat this reversal is more likely to occurr wit hin t h e
nerve ending (. '. acintosh, 1963).
1

In this regard several in-

vestigators have reported that HC-3 can be acetylated by partially purified ChAT, although the identification of t h e a.cetylated product was incomplete (Arnaiz et al, 1970; Bann and
Hebb, 1975 ; Barker and _Uttag, 1975).
The choline analogue triethylcholine (TEC) is capable of
prejunctional blocking action at neuromuscular junction (Bowman and Rand, 1961; 3owman and Hem sworth, 1965; Bowman et
al, 1967), and Bull and nem sworth (1955) and Potter (1968)
have shown that TEC inhibits the transport of ch oline into
nerve endings, suggesting that the pharmacological action of
TEC is a reult of the depletion of available choline for Ach
synthesis, leading to a decreased a.mount of releaseable Ach.
In vitro , partially purified ChAT is capable dlf a.cetylating
the mono- , di-, and triet hy l analogues of choline, with monoehtylcholine (MEC) acetylated almost a.s readily a.s choline,
and the di- and triethyl choline analogues being less acceptable as substrates, respectively (Hemsworth and Smith , 1970) .
TEC was also found to be acetylated in vitro with a K of
m

50mM ( 1ann and Hebb, 1975; Barker and . i ttag, 1975) .

These

studies were important since they suggest that TEC could be
acetylated in vivo, and possibly form a false transmitter in
cholinergic nerve endings.

A false transmitter is

a substance

which is stored by a nerve terminal and released upon nerve
stimulation under cond.!btions whic h ca.use the release of the
physiological transmitter.
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Ilson aDd Collier (1975) have demonstrated that the supcervical ganglion of the cat is capable of taking up TSC,
a.cetylating TEC, and releasing acetyl-TEC in the prescence
of ca+ 2 • Preganglionic nerve stimulation increases both the
uptake and acetylation of TEC, al hough the larg e _proportion
of transported unacetylated TEC (76% of normal ) Suggests
that the process mf transport and acetylation are independent
processes in ganglia. (Ilson et al, 1977), at variance to the
suggestion that choline upjake and acetylation are coupled
(Barker and Mittag, 1975).

In the rat cerebral cortex, 88%

of the total amount of TEC taken up remained unacetylated, and only
3% was acetylated after the tissue had been depolarized for
48 minutes prmor to exposure to nondepolarizing me dium with
10uM TEC (Ilson et al, 1977).Th e characteristics of the release of acetylTEC from brain tissue was similar to the characteristics of Ach release in brain tissue (llsonb et al, 1977);
release was stimulated by high K+ and atropine (Polak and
:11euws, 1966; Bertel-Meuws and :F olak, 1968 ) and was ca+ 2 dependent

( I'~ olenaar

and Polak, 1970;

r-~ olenaar

et al, 1973; Car-

roll and Goldb erg, 1975).
Th e choline analogue homocholine (3-trimethylamino-propan-1- ol) has b een shown to block choline upjake i n synaptosome s (Si mon et al, 1975) and to be tak en up by b oth a h i gh
( Kt=3 u~ )

and a low

affi~it y

( Kt=1 4 . 5u 1) synaptosomal up take

sy stem ( Collier et al, 1977).

Partially purified preparations

of ChAT are unable to acetylate this analogue (Currier and
Mautner, 1974 ; Collier et al , 1977), although synapt osomes
are capable of forming acetyl-homoch oline (Colli er et al, 1977).
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A~

3u~

h omocholine, the percent acetylation of the total amount

of h omocholine transported by synaptosomes is 32%.

The uercent

acetylation of total choline taken up by synaptosomes fro m a
3uT·I choline concentration 50. 5%, indicating that under these
conditions , homocholine is almost as acceptable a substrate as
choline (Collier et al, 1977).

Syna~tosomes

incybated in higher

concentrations of homocholine acetylated a much lower percentage
of the total taken up than syna.ptosomes incubated in higher
concentrations of choline (Collier et al, 1977).
Preganglionic herve stimulation of sympathetic ganglion
accelerates the acrtylation of homocholine in the prescence
of physostigmine , and the amount is 70% of the amount of choline
a.cetylated under comparable conditions (Collier et al, 1976Q,
although homocholine acetylation cannot be demonstrated with
less than 60 minute stimulation (Collier et al, 1977).

The

amount of ho ocholine acetylated by stimulated ganglia is not
enough to replace all the Ach released by nerve stimulation,
and Collier e

al (1977) has suggested t hat the rate of

acetyla.tion is limiting.

Stimulated non-eserinized ganglia

acetylated less than 1016 of the accumulated homocholine, and
release of acetyl-homocholine is Ca+ 2 dependent (Collier et
al, 1977) .

ACETYL CoA AND A1ALOGUES
The acetyl CoA analogues, propionyl CoA and butryl CoA,
can be used for substrates for rat brain ChAT and have affinities
equal to that of acetyl CoA, although the Vmax is decreased
as the acyl chain lengthens (Rossier, 1977).
Acetyl
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Acetyl CoA for Ach synthesis can be produced inside the
nerve ending from ex±racellular glucose, lactate, or pyruvate,
but not exracellular succinate, citrate or acetate (Browning
and Schulman, 1968; Jope et al, 1978).
from pyruvate, NAD + , and CoA by

Acetyl CoA is formed

p~ruvate

dehydogenaase within

the mitochondria (Sandi, 1963; Tucek, 1967).

Transport of

acetyl CoA directly out of the mitochondria is unlikely,
since the mitochondrial membrane is poorly permeable to acetyl
CoA (Tucek, 1967; Lowenstein, 1968).

Tucek (1970) has sug-

g ested that mitochondrial contraction may promote lleakage
of acetyl CoA out of mitochondria.

Other transfer mechanisms

of possible acetyl CoA precursors out of mitochondria i elude
transfer as citrate, acetate, and transfer as acetylcarnitine.
However, the enzymes that catalyze t h e formation of acet yl
CoA from acetate, acetyl CoA synth etase (E.C.Xl 6.2.1.1.,
a.ceta.te:CoA ligase), or from acety lcarnitine, carnitine a.cet yltransferase (E.C. 2.3.1.7.

acetyl CoA:carnitine-o-acetyl-

transferase) are found within the mitochondria (Barker et al,
1968; Neidle et al, 1969).

Acetyl CoA synthetase is not foynd

in sufficient quantities in the cytoplasm to maintain Ach
synthesis (Tucek, 1967).
Citrate is known to be transported into

xprx~±mxEmExx

the cytoplasm of the cell from mitochondria for fatty acid
synthesis ( Barker et al, 1968 ).

Citrate thus transported

could t h en be converted to acetyl CoA by the cytoplasmic
emzyne cjtrate ATP lyase (Tucek, 1967).
that over

80~/o

It has been sugg ested

of the extra.mi to~hon drial acetyl CoA produced

from pyruvate in rc;.t liver mitoch ondria is supplied via
citrate ATP l y ase l
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citrate ATP lyase (Daikuhara et al, 1968).-(-) Hydroxycitrate,
an inhibitor of citrate ATP lyase, also inhibits incorporation
of glucose into brain lipids, sugge sting that citrate conversion
to cytoplasmic acetyl CoA is involved in brain lipid synthesis
( Watson et al, 1969; Patel and Owen , 1976).

Work wth mixed

label glucose gas suggested that citrate is an

in~ermediate

in AcH synthesis (Sollenberg and Sorb o, 1970) and as t h e
i mm ediate precursor to the acetyl moiety of Ach ( Sterling and
O' Neill, 1978). The latter investigators have sh own that the
3 H/ 14 c ratio of Ach produced is equivalent to the 3H/ 14 c ratio
of Xzx acetyl CoA produced by citrat e ATP lyase, the citrate
bEing produced intramitochondrially from 6( 3H, 14 c)glucose.
However, the 3H/ 14 c ratio of Ach produced in the prescen ce of
inhibitors of citrate cleavage, such as -(-) hydrOX'Jcitrate,
and n-butyl malonat e, an inhibitor of citrate transport (Robinson and Chappell, 1967) is significantly higher t ham the
ratio obtained in the abscence of inhibitors (Sterling and
O' Neill, 1978), suggesting that alternative sources of acetyl
CoA foE Ach synthesis exist.

It is important to note , however,

that other investigations (Tucek and Cheng, 1974; Lefresne et
al, 1977) have found that labelled citrate, which had entered
the tissue, is not significantly incorpoated into Ach either
in vitro or in vivo.

X~:liX.H}UUa!X:IHXIlXXXE::XXXpp~I::U:XX

Feigenson and 3arrnett (1977) have sugg ested that endogenous acetyl CoA stores are capable of producing a significant
amount of Ach.

It should be noted, however, that the source

of endogenous acetyl CoA is undetermin ed, and could be for med
by alternate pathways to the citrate pathway .

In brain tissue,
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acetate is not a precursor for Ach formation (Scuberth, 1965;
Tucek, 1967; Neidle et al, 1969; Aas , 1971), as it is in
neuromuscular junction (Dreyfus, 1975).
:-~ orot-Gaudry
~orpedo

Recently , diebler and

( 1977) have found that, in the electric organ of

marmaruta, acetyl CoA synthetase is 30 times less ef-

ficient in producing acetyl CoA than

ChA~

under optimum con-

ditions , suggesting that this could be an alternative pathway
of acetyl CoA 9roduction in brain tissue as well.

Gibson and

Blass (1976) have reported that Ach synthesis in mouse and
ra.t brain is related to the NADt:. ADS: ratio in both the cytoplasm and a.cross mitochondrial membranes , but may not be related to a decrease in ATP or adenylate energy charge.

These

results i mply that several sources of acetyl eoA fo r Ach
synthesis may exist.

REGULATI03 OF ChAT
Regulation of Ch.AT activity is beleived to exist peripherally ,
since Ach release promotes increased synthesis so that tissue
levels are maintained at normal levels (Birks and Aacintosh,
1961; Br i.vning ang Schulman, 1968; Carroll and Goldberg , 1975;
Sac chi et al, 1978).

This regulation may occurr by product

inhibition, but Ach has been found to be a weak inhibitor a.nd
is only capable of a 50:6 inhibition of enzyme activity a.t Ach
concentrations of 100mM or more ( Potter et a.1,1968; Kaita and
Goldberg , 1969 ; Glover and Potter , 1971).

Eeterogeneity may

exisrt, since Singh et al (1975) have reported that one molecular form of ChAT , a low activity form, is less resistant to
Ach inhibition than a higher activity form . CoA is a much
more effective inhibitor of Ach synthesis, but the accumulation

-27of CoA under physiological conditions is thought to be unlikely,
since the ratio of CoA to acetyl CoA would be expected to
change during Ach release, an& these changes would affect the
synthesis of other acetyl CoA requiring materials such as fatty
acids (P-ebb, 1972).
Another possible
a~ailability .

waj~

ChAT may be regulated is by substrate

For acetyl CoA to limit the activity of ChAT,

its availability would have to increase during Ach release.
while no direct evidence exists that supports this possibility,
it is beleived that Na+ , whose intracellular levels increase
as a result of depolarization, increase the oxidation of glucose to

co 2

((Diamond , 1971), suggesting that the amount of

Krebs cycle intermediates produced may be enhanced.

It should

be noted that Ach synthesis is beleived to be somewhat Na+
dependent ( ~ann and Hebb, 1975; Hersh et al , 1978; Jope and
Jenden , 1978), as is high affinity choline uptake (see Kuhar
and f·'. urrin , 1978) .

Conditions of hypoxia or hypogy lcemia

inhib it the production of Ach (Gibson and Blass, 1977) .
ThE rate of Ach synthesis in nerve terminals may be related to hi gh affinity choline ;¥ptake (3 arker and "'"iittag, 1975;
Guyenet et al, 1973) , and this uptake mechanism may b e stimulated by in vivo treatment with drug s t hat lower levels of
brain Ac h (Jenden et al, 197 6) or direct electrical stimulation
t hat stimulates nervous activity (Simon and Kuhar, 1975; Atweh
et al, 1975; Simon et al, 1976) .

High affinity choline trans-

port is reduced or lost in depolarized in vitro preparations
(Carroll and Goldb erg, 1975; ,T urrin and Kuhar,- 1976 ; Vaca. and
:B each , 1977), and choline uptake is accelerated (Rosk owski, 1978),

-~probably mediated by the low affinity transport system, and
acetylated efficiently,

Experiments with sympathetic ganglia

suggest that preganglionic nerve stimulation increases the
total uptake of choline (Collier and ··iacintosh , 1 969 ; Collier
1

and Zatz , 197 6), and de- emphasi zes the i mp ort an ce of hi gh
affinity ch oline uptake for Ach synthesis in ganglia . Furt hermore , lesioning of the preganglionic nerve terminal has n o
influence on choline transport supplying the substrate for
acetylation ( Katz and Collier, 1974).
It has been sugg ested that neuronal activity may increase
t h e production of ChAT in the cell b ody ( Oe ch, 1974), but it
is beleived that enzym e activity is not rat e limiJing for
Ach synth esis, since Ach synthesis by brain in vivo is approxi mately 30 fold less than that found in vitro (Schuberth et
al, 1970; Hebb, 1972; Saelens et al, 1973; Jenden et al, 1974)
and inhibitors of ChAT do not appear to lower Ach levels
(Glick et al, 1973; Krell and Goldberg, 1975).

If neuronal

activity enhances ChAT production an d ChAT were rate limitin g ,
the amount pf Ach syn thesized in the tissue during depolariz a tion
would be expected to increase.
peripherally.

This is not beleived to occurr

It may be possible that the enzyme may be re-

leased during depolarization, since dopamine beta hydroxylase
has been shown to be released (DePotter and Chubb, 1971).

THE QUANTAL THEORY

A.~D

VESICLE HYPOTHES IS

The existence of minut e transient fluctuations in voltag e
(m.e.p.p. 's) at neuromuscular junctions ( Fatt and Katz, 1950;
195~)

and at central synapses in spinal motoneurons (Katz and

-29-

Miledi, 1963) are beleiv d to represent the release of quantal
units of transmitter, such as Ach, into the synaptic cleft.
Furthermore, m.e.p.p.'s exhobit a regular size and time course,
indicating that these changEs in the end plate potential are
not due to leakage of Ach, but from the simultaneous release
of thousands of Ach molecules which are highly concentrated
(Katz, 1966).

The realease of these multimolecular packets

of Ach in an all or none fashion from discrete points of the
terminal axon menbrane is the basis of quantal spontaneous
release ( Katz, 1966).

Ea.c hquantum of Ach is thought to con-

tain 5 ,000 to 10,000 molecules, and the release of large number s of
quanta is thought to cause t h e g eneration of an end plate
potential or a postsynaptic potential (Katz and Miledi , 1963;
Katz, 1966; 1969).
The significance of the quantal t he ory was enhanced by
the electron-mi croscopic observation that synapti c vesicles
(40-50nm in diameter) were concentrated at both neuromuscular
junctions (Robertson, 1956) and central synapses (DeRobertis
and Bennet, 1954; 1955; Fernandez-Moran, 1957).

Subcellula.r

fractionation studies found that pin ched off nerve endings ,
or synaptosomes, contained Ach, Ch.AT, and AchE, and vesicles
contain the highest concentration of Ach (Whittaker , 1959 ;
Gray and ·,'/hi ttak er, 1962; DeRob erti s et al, 1963; Whittaker et al,
1964; ','/hi ttaker and Sheridan , 1965).

The relationship between

the sy apyic vesicles and Ach led to the develo pment of t h e
vesicle hypothesis, which states that the transmitter substan ces
are stored within synaptic vesicles which are then conveyed
to the presynaptic membrane by some unkown process , and the
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release of one±x vesicle's content correspomds to the release
of one quantum (Jones, 1975), although most estimates of vesicle content indicate that a one-to-one relationship between
quantum and vesicle is unlikely ('.'/hi ttaker, 1970; Whittaker
and Sheridan, 1965).

It should be noted, however, that the

quantal nature of Ach release in cerebral cortex has not been
demonstrated.

The response to Ach by cholinoceptive cells is

slow and prolonged in cerebral cortex (Krnjevic et al, 19719),
while a rapid and brief response to Ach is seen at the endplate
region of skeletal muscle (Krnjevic and Miledi, 1958) .

POOLOOF Ach

FREE Ach
20- 30% of the total brain Ach content is released upon
homogenization, is susceptible to AchE hydrolysis (Crossland
and Slater, 1968; Tobias et al, 1946), and is thought to be
outside of the nerve ending, probably that present in cholinergic
axons, which are known to contain Ach along their whole length
( 'lacintosk, 1941).

The source of the Ach in the axon maybe

due to the fast axoplasmic transport of Ach storage particles
or Ach bound to particles (Evans and Saunders, 1967 ; Schafer,
1973) , or the simultaneous transport of ChAT, choline , and
acetyl CoA (Fonnum et al, 1973; Hodgkin and Martin, 1965).
The functional significance of this pool of Ach is unknown.

:S OL D Ach : CYTOFLAsrr rc AND VESICULA.:.-q
ThE remaining Ach is bound within synaptosomes, and these
particles can be disrupted by hypo-osmotic treatment (DeRobertis
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et al, 1963; Whittaker, et al,1964) or pressure under isoosmotic conditions (Ta.keno et al, 1969).

After syna.ptosomal

rupture , about half of the total bound Ach is released and
is susceptible to AchE hydroylsis (cyto plasmic Ach); t h e remaining Ach (vesicular Ach) is protected from Ach3

a~d

is

fo und in the pellet of hi gh speed centrifugation of lysed
synaptosomes ( DeRob erti s et al , 1963; Whittaker and Sheridan,
1965) .

Exposing intact cerebral cortex to radioactive choline

has been shown to labell these two nerve ending stores with
specific a ctivities (Aquilonius et al, 1973 ; ffolenaar and
Polak , 1973 ; Mol enaa.r et al, 1973; Ric ht er and

-~ archbank s ,

1971 ),

and the amounts of choline present in t he se stores can change
independently (Collier et al , 1972), suggesting that cytoplasmic Ach is at least not entirely due to leakage from vesicular Ach .

LOCALIZATION OF ChAT
Fonnum (1975) has estimated that in the CHS , 5% of the
total ChAT activity present ms localized in the cell body,
15 - 25% in the axons and dendr ites , and 70- 80% in the nerve
terminal .

It was found that the location of ChAT within t h e

nerveterminal , between the cyt oplasm and membrane particles,
including vesicles, was affected by the severity of the treat ment used t o hypo- osmotica.l ly shock synaptosomes , since
DeRobertis et a l (1963 ), who resuspended sJna.ptosome s in 910 mls of water per gram of tissue, found t hat ChAT was localized with heavy membrane particles, including vesicles , and
Wh ttaker et al , (1964) , who resuspended synaptosomes in 2ml
of water per gram of tissue , found that most of the ChAT was
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activity appearred in the hi gh speed supernate, sugge sting
cyt oplasmic location.

An explanation for these apparently

diverg ent results was found by Fonnum (19 67; 1968) who found
that t he proportion of solub ilized to membranee bound ChAT in
synaptosomes was largely a function of the ionic strengt h and
pH of the suspending medium , maximum release of membrane bound
enzyme occurring at an ionic strength of 150mM and a

p~

of 7.4.

Furt hermore , these studies suggested that species specificity
is a factor, since rabbit and rat brain ChAT is more resistant
to solubilization than ChAT from guinea pig and pigeon enzymes.

C~ASSICAL

HYPOTHESIS .

Based on these findings, the classical hypothesis of Ach
synthesis, storage and release was formulated by Fonnum (1975).
Ac cording to this hypoth esis, all Ach synthesis occurrs in the
nerve ending cytoplasm, where the majority of ChAT is localized
(Fonnum,1967; 1968).

During nErve depolarization, Ach is re-

leased from the vesicular stores of the nerve terminal , and
the Ach synthesized in the cyt oplasm is t h en beleived to be
transported b;t some mechanism into vesicles, and then released.
A p ossib le mechanism for t h e release of Ach from vesicles has
b een envisioned by Katz (19 69 ), in which vesicles release t h eir
contents upon collision with reactive sites at the sjmaptosomal
membrane .

Th e ch oline upt ake system , most probavly the hi gh

affinity sy stem, is beleived to supply the cy toplasm with the
choline necessary to maintain intracellular Ach lev els ( Fonnurn , 1975).
Th e major weakness of this hypothes is is that two pools
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of Ach a.re found in synaptosomes, t hecytoplasmi c and vesicular
pools, and only one site of synthes is, t he cy to plasm (see Hebb,
1972; see .?annum, 1975).

The transport of cytoplasmic Ach into

vesicles above diffusion levels has not yet been shovm ( '·'.arc hbanks, 19 68 ; Katz et al, 1973; Susz kiw and ? ilar. 197 6 ; Carroll
and Nelson, 1978 ), although binding of Ach to vesicles has
been demonstrated ( O' Brian

1976) .

The inability of vesicles

to concentrate Ach supplied extra.vesicularly questions t he
supposed transf er of Ach from the Cytoplasm to the vesicles,
since the vesicular concentration of Ach is estimated to be
considerably higher t han cytoplasmic Ach .

Furt hermore, it

has been reported that the vesicular pool of Ach can empty and
be refilled independently of the cy toplasmic pool (Carroll and
Yelson , 1978), and that all of the vesicular Ach is replaced
with newly synthesized Ach formed from extracellular choline
rather thazn extracellular Ach .
These investigations also suggest that synthesis of Ach
destined to be incorporated in the vesicles occurrs at aome
other site than the cytoplasm .

It should be noted t hat Ku c-

enski et al (1975) described a membrane bound form of ChAT
from rat brain,and two components of Ach synthesis have been
observed in brain cells in culture (

)•

Recent

cytochernical studies have suggested that at least some ChAT
is associated with vesicular membranes (Fei gen son and Barrnett,
1977) and the number of vesicles present in the nerve ending
may be related to the amount of active ChAT which can be found
on vesicular membranes (Barrnett et al, 1978 ) .

Hattori et al

(1976) has also reported that ChAT may be associated with
both the outside of vesicular membranes and possibly intra-
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vesicularly .

The mean half life of vesicles, 21 days, (Arnaiz

et al, 1970), agrees well with the estimated half life of
ChAT, 12-20 days (Fonnum et al, 1973) .
Arguments against the intravesicular location of BhAT
state that acetyl CoA generating enzymes, which have not been
found in vesicular fractions of brain (Tucek , 1967), must be
present, along with substrate and ATP .

However, Feigenson

and 3arrnett (1977) found that an endogenous pool of acetyl
CoA in rat brain synaptosomes which is able to support Ach
synthesis at

2a~

of normal amounts .

The work of Lai et al

(1977) may provide evidence t hat the vesicular fraction of
acetyl CoA may be related to t he apparent heterog eneous natur e
of brain mitochondria. (Van der 5 erg, 1973) .

Two mitoctondrial

populations were found in rat brain, and both fractions were
contaminated with membranes and Vesicles .
Another argument a gainst t he intravesicular production
of Ach involves the generation of intravesicular CoA, a
stong inhibi tor of ChAT (Potter et a.l , 1968; Glover and !}otter ,

1971; Hebb , 1972), and would not allow t he intravesicular Ach
con c entration to reach more than micromolar levels , a.ssrnning
that CoA cannot be transported out of the vesicle .

FHIE STRUCTURE OF THE PRESY_JAPTIC l: ERVE

TERJ'.~ LJAL

Several structures have been identified in the presyna.ptic nerve terminal (see Jones , 1975; 1978 ).
ma~

The se structurs

indicate that the activities of the cytoplasm do not occurr

in a. random fashion .

-35-

The MXM±xIDIEHX orderliness of the area at the presynaptic terminal is emphasized by the urescence of a presynaptic
vesicular grid, which appears to define the sites at which
the vesicles can make contact with the presynaptic membrane
(Jones, 1972).

The observation that dense projections,exist

as regularly arranged profiles projecting from the presyna.ptic
membrane into the cytoplasm (Gray, 1963; 1966) may suggest
that these projections a.re involved in drawing synaptic vesicles towards the presynaptic membrane prior to neurotransmitter
release (Gray, 1966).

Seversl investigations have suggested

that dense projections are essential to presynaptic organization (Akert et al , 1969; Pfenninger et al , 1969; Akert, 1973) ,
since they may be the nodal points of hexagonally arranged
vesicles (Akert et al , 1969;1975; Akert and Pepu, 1975) and
interconnected by filamentous strands .
Protuberances along the presynaptic neuronal membrane may
represent temporary attachment sites for VEsicles and constitute
channels for the release of neurotransmitters from the vesicles
trhough the presynaptic membrane (Del Castillo and Katz, 1957),
or the protubErances may be the result of the release of
neurotransmitter by an exocytotic mechanism (Streit et al, 1972;
Jones, 1975) .
Although vesicle loss upon st i mulation has been observed
by Barrnett et al ( 1978), the phenomenon is not well established
(see Boyne , 1978).

The long half life of vesicular membranes

(Arnaiz et al , 1970) may be interpreted as evidence against
exocytosis as a me chanism for transmitter release , s i nce exocytosis implies single usage of the vesicle, and therefore a
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high turnover rate (Cooper et al , 1977).

Furt h emore, Barker

et al (1970) has suggested that the protein and lipid profiles
of the vesicular and nerve terminal membrane are different,
i mply ing t hat fusion of vesicles with the nerve termi nal membrane is unlikely .

Another exp! anation for vesicle loss may

be an alteration in vesicular sha p e and confi guration .

After

stimulation, vesicles app ear to be come elliptical in fro g
neurmuscular junction ( Eeuser and .rteese, 1973).

In a pp ar ent

support of exocytosis, vesicles a pp ear to be released f r om
electric organ of t h e electric ray (3 oyne et al,

19 7 5~

and

fro m cat superior cervical ganglion (!ys h and .v iley , 1974 ) .
Coated v esicles, wh ich have b een assigned roles in t h e
unfolding and fissioning of cell membranes (Roth and Porter,

1974), the cellular uptake and transport of proteins (Roth
and Porter , 1974; Friend and Farquhar, 19 67; Bowers , 1964)
and enzymes (3roni et al , 1965; Holtzman et al, 1967), consist
of a central vesicle surruonded by h exagonal and pen tagonl
s hapes ( Kanaski and Kadota , 1969; Xadota et al, 197 6) composed of one protein, clathrin (Pearse, 1975).

Coate d vesi-

cles have hi gher activities og certain enzymes t han nlain
syna.ptic vesicles ( Kadota and Kadota, 1973) and vesicular
choline is preferntia.lly associated with coated vesicls, while
vesicular Ach is predominant in plain synaptic vesicles ( Kami y a et al , 1974) .

Coated vesicles also app ear to be prefern tially

located in t h e uytoplasm of the nerve ending ( Gray, 1972; Jon es
and Bradford , 1971) , and have been i mplicated in t h e transfer
of membrane between t h e presynaptic and vesicular membran e s

C· arc hbanks, 1976).

The presynaptic network is beleived to be
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•

of a microfilarnentous nature of unKn.own comp onents , extending
throughout the presynaptic terminal and attac hing at various
points along t h e inner membrane of t h e presynaptic termi nal ,
and may condense during fixation procedures to artifactually
create coated vesicles (Gray , 1972; 1973; 1975).
It has been found b;

Gra~

(1975) t hat mi crotubules can

be found in presynaptic nerve terminals, amd other i nvestigat!~~s

have implied a close association of vesicles and micro-

tubules in axons of larval lamprey spinal cord ( Smi th et al,

1970; 1971).

Complexes of microtubules and smooth endoplasmic

reticulum have been found in CNS tissue, but rarely at presynaptic nerve terminals ( Grahinger and James, 1969 ; Lieberman, 1971).

Microtubules are beleived to be involved in rapid

directional translocation of intracellular particles ( Smith et
al, 1975).

In nerve cells, t h ey may be involved in axo plasmic

transport (Paulsen and McClure, 1975).

The mitotic inhib itdms

viblastine and colchicine disrupt tubulin polymers and

xx~ixx

block rapid transport of protein ( Karlsson ans Sjostrand, 1969;

1971) and noradrenergic vesicles (Banks et al, 1971; 1972).
The rate of tubulin production may be associated with functional
stimulation, since eye opening causes a rise in tubulin

~XE*

«xz±±mr synthesis in visual cortex (Roset et al, 1976 ; Cronly-

Dillon and Perry, 1976).
Actomyosin proteins have also been found in presynaptic
terminals ( Fine and Brag, 1971; Pushkin and Berl, 1972; Bunge ,

1973 ).

It ijas been postulated that an interaction between

membrane associated actin and cyt oplasmic myosin may draw t he
synaptic vesicles towards the terminal membrane (Le Beux and
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1.v illemot, 1975).
Synaptosomes have been shown to contain some of t h ese
structures (Jones etaal, 1975).

Syna-ptic ves·icles, coat ed

vesicles, and dense core vesicles have b een found using combined aldehyde-Os o4 fixation and staining with uranyl and
lead salts ( Kuriy ama et al, 1968; Ross et al, 1971; Dowdall
and Whittaker, 1973), and dense projections an d t h e presyna.ptic network have been revealed have b een visualized u sing a
n on -osmicated fication techniqu e (Eloom ans Aghajanien, 1966 ;
Jones , 19 69 ; 19 70) •
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IR3:!=ARATIO~J

OF r:OUSE R. ATIT

1ale (CD-1) albino mice

CEOL II\E- 0 - AC~TYL'.i1Rfl3 SFEAS:S

were killed by cervical disloc -

ation in a cold room (4 C), t he brains quickly removed, and
placed in several hundred millimeters of ice-cold O. 32f·l
sucrose (isotonic sucrose).

The brains were then blott ed dry,

the cerebellum, pons , medulla , and optic buttons excised ,
and sectioned through the medial sagg ital fissure.

The bra.i n

halves were weighed, minced, and stored on a petri dish on
ice until the onset of incubation.
To reduce the tissue levels of Ach whic h may be inhi b itory
to the enzym e ( Potter et al, 1968 ; Kaita and Goldberg , 1969 ;
Glover and Potter, 1971), the brain minces , wieghing approxi matelt 150-200mgs, were incubat ed in 8 mls of 35 mMK+Krebs
bi carbonate buff er rnEdi um( /Ot>-mM 3 aCl; 3/

mMKCl; ;<;~; mM Ca.Cl ;
2
; J/ .l/ mrti glucose) at

/. .l KH 2Po 4 ; L'-mM Mgso 4/7H20 ; ~P. 0 Il11 1 ~:c.o 3
37 C for 4 minutes under 95% o2- 5% co 2 in a Dubnoff me tabolic
shak er, set a 90 cycles/minute (Salemoghaddam and Collier , 1976;
Carroll and Goldberg , 1976).

The incubated minces were then

washed twice with ice-cold isotonic sucrose, and subeellula.r
fractions prepared according to the method of Gray and Whittaker
(19 62 ) as modified by Collier et al (1972) and Sa.lemoghaddam
and Collier (1976) (see Fig . 1) .

The washed minces wqre hom o-

genized in 5 ml of isotonic sucrose at 840 RP.'·1 using 8 up and
down strokes in a. Teflon to glass homogenizer, with a clearance
of O.O~~cm .

This initial homogenate was centrifuged at 4 C at

1000g for 10 minutes and t h e pellet, P 1 , which is composed
:primarily of nu clear debris and myelin , was discarded. The
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supernate,

s 1 , which incllil.des nerve ending synaptosomes, was

centrifuged at 17,000g for 15 minutes .

Following this cent-

rifugation, the supernate (s 2 ), which contains microsmes, was
discarded . The synaptosomal fraction ( P 2 ), which ENXi~:bl~ is
rich in synaptosomes (De Robert is et al , 1963; Gray and ;'Jhi ttaker, 1962; Whittaker et al, 1964) , was the hypo- osmotically
shocked in 2 mls of ice cold glass distilled water, pn 4 . 0,
and homogenized at 400 RPr· with a Teflon to glass homogenizer
using 8 up and down strokes , i n a effort to maximize synaptosomal rupture .

This homogenate was then centrifuged at 100 , 000g

for 60minutes to yield a pellet (P ) and a supernate (s ) .
3
3
The P fraction , or the crude vesicular fraction, consists of
3
synaptic vesi cles , ruptured synaptosomal menbranes , m~tochondria ,
and most of the synaptosomal ChAT activity, since ChAT has been
shown to bind to membrane s under conditions of low ionic
strength (Fonnum , 1967; 1968) .

The

s 3 fraction c ontains cyto-

plasmic Ach and other cytoplasmic constituents .

The F

frac 3
tion was then suspended twice in one ml of 100mM sodium ph osphate buffer , pH 7 . 4, ionic strength 160mM , and centrifuged for
60 minutes at 100 , 000g .

Th e supernates from t h ese two centrif-

ugations were then comb i ned , and contain t hat fraction of
synaptosomal Ch..AT wh ich is ioni cally bound to membranes after
hypo- osmotic synaptosomal rupture , and "b elei ved to exist freely
in t he cytoplasm of t he cholinergic nerve ending in vivo ( Fonnum, 1967 ; 1968; 1975) .

The washed P

3

fraction was then sur-

face washed twice with 10mls of glass distilled water, pH 4 . 0 ,
i n an effort to redu ce endogenous choline .

The enzyme activity

in t he washe d crude vesicular fraction is beleived to be du e
to a form of ChAT which is non-ionically b ou...YJ.d to membranes or
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membrane organelles .
ThE recivery of

ChA~

and protein of the synaptosomal

fraction (? 2 ) is shown in Pig . 1.
A3SAY FOR ChAT ACTIVITY
Ch...AT activity in t h e mouse brain sucellular fractions was
determined by the procedure of EcCamen and Eunt (1965) as modb~

ifoed

Spyker et al (1972).

In this procedure, a saturating

acetyl( 14 c)CoA concentration and various concentrations of
unlabelled choline are incubated in a 200rnM sodium ph osphate
buffer , pH 7. 4 , in the prescence of an aliquot of the

subce~ -

lular fraction in auestion .

Aliquot volume was 2ul, and the
buffer substrate mixture, containing acetyl( 14 c)CoA, choline ,
sdi um phosphate buffer ,

NaCl,

had an aliquot volume of 20ul .

MgC1 2 , and 70mg/ml protien ,
The acetylated product was ex-

tracted from Jhe inuubation mixture with 5mg/ml sodium tetraphenyl boron in 3- heptanone via cation exchange (Hebb et al,
1975) .

Tissue- free samples were run as blanks .

~XK~~

Imidazole groups have been implicated as activators

of the non- enzymatic production of Ach from choline and acetylCoA (E Hebb et al, 1975 ; Aquilonius , 1976) .

Therefore , control

(tissue- free) and enzyme containing incubation mixtures were
boiled for 5 minutes ,

an~

found to be not to be significantly

different from values obtained for the

nonbo!I~dcontrol

control

(tissue- free) incubabation mixture . i
Protein was determined by the method of Lowry et al, 1951 .
DECSENDING PAPER CHROMATOGRAPHY

D:SCSENDI_.G PA:P:IB CHR0Iv1..ATOGRA:PrIY

Ach (and other acetylated products) extracted into sodium
tetra.phenyl boron in 3-heptanone was extracted into 0 . 4N HCl

~ftfl

recovery of8:.J% (Nelson, personal communication), and

lyophilized and concentrated several fold.

The concentrated

samples were straked on '.1'/hatman 3 0 . 5 chromatogrm pa.per and
developed, in a descinding fashion, in a solvent system of
n- butanol-azEi:izxaz:i!li: ethanol- aceti c acid-distilled water
(8:2:1:3, v/v) at room temperature for 8 hours.

An Ach standard

(unlabelled) was co-chromatographed and ita position detected
by iodine vapor (Brante, 1949).

The developed chromatograms

were cut into 1 cm strips, eluted with 1 ml of hyamine- methanol
(1:2) v/v), and counted by liquid scintillation spectrooetry,
using a tolune based fluor.
In some experiments, the incubation mixture contained no
xi:miiadded ch oline , and endog enous stores of s ub strates for
mouse brain ChAT, including ch oline, were acet ylated wit h
acetyl( 14 c )CoA. The prescemce of Ach and at one other acetylated compound with a quaternary ammonium group has been determined under these conditions.
In other experiments, a vast excess of Ac hE was present
in t h e incubation mixture, based on t h e amount of Ach formed
by t h e fraction under study, and the :presc en ce of non- hy drolyzed Ach was confirmed by descending pap:er chromatography .

I ~E IB I T ION

STUDIES

Solutions of 4-( 1-na.pht hylviny l)pyridine ( 4- NVI' ) were
prepared i n amber bottles, since

4- N~

is li ght-sensitive
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(°.lhite and Cavallito, 1970) .

The increas e in volmme of the

incubation mixture was 1 ul, and t he i ncr ease in total volume
did not effectively dilut e t ha Ach pro duced.
Wh en the effect of 4-NVP was measjlr ed in vivo, mice were
pretreated with either an i.p. injection of 4- NVP in salin e or
an equal volume of saline , and were Killed by c ervical dislocation 30 minutes later.

Subcellular fractions were nre-

pared as descibed as above, and ChAT activity was determined .
Inhibition of mouse brain ChAT in vitro by Ach was investigated by adding 1ul of a highly concentrated Ach solution
to the incubation mixture immediately before t h e incubation
dif t h e sample, in an attempt to decrease t h e amount of choline
produced by the reverse reaction of ChAT from the added Ach .
The forward reaction is hoghly favored and has an equilibrium
constant of approximatel 500 ( Potter and Glover, 1971).

LOCOAOTOR ACTIVI TY

rfiEA S UR:Ef'.~ENTS

In these experiments, 4 mice were injected i.p. with
200mg/kg 4-NVF , an equal volume of saline, or not injected,
the latter acting as a control for injection.

Locomotor act-

ivities were determined for gruop of adult mice in activity
chambers equipped with a Selective Activity Meter - Model S
and activity measurements were recorded at 15 minute intervals.
Two different chambers were used, and the activity obtained
at t h e initial 15 minutes for the non-injected control group
for each activity chamber was arbitrarily set at 100%.
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AHALYS IS OF EIJZYEE KI NETICS

The steady state kinetics of the great majority of enzymecatalyzed reactions can be described in terms of a hyperbolic
relationship between the velocity of the reaction, defined
in this study as the activity of ChAT at a known choline concentration, and the concentration of choline involved (Roberts,
1971). The doble reciprocal plot, in which 1/v is plotted a gainst
1/s, is by far the most widely used transformation to study
enzym e kinetics (Lineweaver and ::: urke, 19

)•

This transfor-

mation was used in this study.

S'I'A·r ISTICS

_h e statistics used in t his investigation inclu de t he
pa.ired and independent t-tests, as described by Lentner (19 75).

LI M ITATIO ~ S

OF THIS ST JDY

The major assumntions of this approach include the use
of high potassium concentrations to indu ce vesicular Ach release as a valid techni qu e (Liley, 195 6 ; Kat z, 1962; Gaye,
19 67), and t hat Ch.AT is specific for ch olinergic neurons
(Fonnum, 1979).

The major weakness of this approach is that

central Ach metabolism is studied in an in vitro preparation
which has been estimated to beonly 15% cho linergic (Macintosh ,
), and the degree of interaction with n oncholinerg ic
neurons has not been determined.
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I·~ ATIBIALS

Acetylcholinesterase(AchE ) and 4- lTV_ were purc hased from
Sigma and Calbiochem , repectively.

2- Diethylammnoethanol and

ethy l iodide , the corresponding amino alcolholx and alky l
iodide for the synthesis of triet hylcholine (T EC ), were supplied by Eastman and Fischer Scientific , respectively .

3- Di -

methyl amino-1- propan ol and methyl iodi de , the corresponding
amino alcohol and alkyl iodide for t he synth esis of h omo choline,
14
.
were supplied by Al drich Chemical. Acety l( C)C oA was purchased from 3 ew England Nuclear, with a specific activity of
/(),I ~1 {~/1.

Scl.'1,..,+J\c

•

Toluene and Liquifuor were purc hased from
a.lhJ

Nflw

CZill5ltri-ld N ..1 ci~a.Y.J re~fecfi'oel~.

F 1 S<. he V'

- 46The subcellular fractionation proc e dure u sed in t!:lis study
is desci
is described in Fig. 1. The recovery of synaptosomal ChAT and
and protien is shown in Ta ble 1, and these results are similar
to t h ose obt ained by

F onnu~

(19 68 ).

T!:l e results shown in Fig. 2. i nd icate t hat b oth t he solub i lized and membrane b ound for ms of mouse brain nerve ending ChAT
can linearly acetylate choline for 30 minutes , when saturated with
both choline and acetyl CoA at 39 C.

The membrane bound form of

t he enzyme appears to a.cetylate choline linearly for almost an
hour under these conditions .

The nonenzyma.tic conversion of ch oline

and acwtyl CoA to Ach has been shown to exist and be enhanced by
imidazole groups in extracts of rat brain ( Hebb et al , 1975) and
human cerebroepina.l fluid (Aquilonius and Eckernas, 1976) .

Tt test

the possibility that nonenzymatic production of Ach was occurring,
both the solubilized enzyme form , present in the combined sodium
phosphate wash fraction, and the membrane bound form of ChAT , present
in the washed crude vesicular pellet , was boiled for 5 minutes
and their respective abili ties to form Ach from satura.ring levels
of choline and acetyl CoA determined .

5 oiling reduced the activity

of both enzyme forms to the level of tissue free blanks, suggesting
the a.bscence of nonenzymatic Ach

production in these subcellu-

lar fractions .
Some reports suggest that Ach may regulate the activity of
bra.in ChAT by mass action ( Potter et al , 1968; Glover and ? otter,

1971) .

Solubilized rat bra.in ChAT is also capable of producing

acetyl CoA and choline as products , but the Ach synthesizi:rlg direc tion is favored , with an equilibrium constant of 450 (Glover and
Fatter , 1971) .

The physiological importance of Ach inhibition of

ChAT has been investigated by Harris et al (1978) .

These inves-

- 47ti gat ors have suggested that synthesis of new Ach in vivo is inhibited by acetylch olinesterase inhib itors, whi ch preserve released
Ach , and atropine, which is beleived to bind y o presynaptic receptors,
and acts to reduce the amount of Ach released.

Several investi-

gators have reported that total synapto somal ChAT activity is
not inhibited more than 50% at Ach concentrations of 100-150mM
(Potter et al, 19 68 ; Kaitia. and Goldberg , 1969; Glover and Potter,
1971) .

Recently, Singh et al (1975) hav e reported the isolation

of a low activity for m of ChAT which is resistant to innibition by
high concentration s of Ach, which are capable of inhibiting a higher
activity form to a greater degree .

Th erefore , the inhibition of

both the solubilized and membrane bound enzyme forms by Ach was
investigated in t his stu dy .

Th e r esults pre s ented in Table 3 indi -

cate t hat t h e membrane b ound enzyme form is less resistant to

~ ch

inhib ition at Ach concentrations greater than 15 0mf.l than the solubi lized form of Ch.AT.
It sh ould be noted t hat exogenous Ach con centrations referred
to .IDn t his experiment ar e extra.vesic ular.

This exog enous Ach oay be

se:parated fro m a fraction of t h e memb ran e 'oound ChAT , t hus accounting
for the incomplete inh i b ition of total membrane bound Cl:.AT activity .
Since vesicular Ac h but not cyt oplasmic Ach is protected from
AcgE hydrolysis, ( Whittaker et al, 19 64 ; Whittaker and Sheridan , 19 65 ),
the ability of the sub cellular fractions to pr odu c e Ach at saturating
levels of ch oline and acety l CoA in the pr es c en ce of a 100, 000
fold excess of AChE was tested.
veal t hat approximately

40?-~

These results (s ee Table 4 ) re-

of the control level of Ach was main-

tai ned in the washed crude vesicular fraction, but 97% of the Ach
produced by the solubilized enzyme form was hydrolyzed .

~he

identity

- 48of the nroduct resistant to hydrolysis present i n t he crude vesicular
fraction wa.s found to be Ac h wit h descemiing pa.per chromatography .
~h il e

these results ma.y indicate t hat a portion of the enzyme

present in the washe d crude vesic ular fraction is protect ed from
t h e effect of an excess of

A c h~ ,

it is possible t hat enclosed ves-

icles are formed during t he initial hom ogB:n iza.tion of the brain
minces, which may repr e sent entrapped cytoplasmic comp onents , ineluding cytoplasmic ChAT.

If this were occurring , t h e addition of

an excess of AchE to the brain minces durin g the initial h omogenization would case the incorporation of AchE into t he se artifactually produced vesicles, thus hydrolyzing the Ach produced by Ch.AT
in this location.
duction in Ach

However, when this experiment was done no re-

produc~ion

was found in either the combined washes

of the crude vesicular fraction, representing cytoplasmic ChAT of
the nerve ending, or t he washed crude vesicular fraction, representing membrane and perhaps vesicular bound ChAT.

However, 90/t

of the Ch.AT activity not bound to membranes following hypo-osmotic
shock of the synaptosomal subcellular fraction was inhibited .
The ions Na + and Cl - have been implicated as activators of
brain ChAT activity ( Potter etyal, 1968 ; Hebb et al, 1975; Rossier,
19~7;

Hersh et al, 1978) and uptake of choline (see Kuhar and

Murrin, 1977).

To determinr if the membrane bound and solubilized

forms of ChAT have different degrees of dependency on the pres cence
of >Ta.+, bot h enzyme forms were incubated in lowered Na.+ conc entrations (see Table 5, .

It is apparent that both for ms of ChAT are

dependent on Ha + , although the membrane bound form was less inhibted
(62;~ )

t han the solubilized form, which was inh ibit ed to nondetectable

leve!ls.
Styrylpyridine analogues, such as 4-(1-na.hthylviny l)pyridine
(4-NVP) are p otent in vitro inh ibitors of solubilized ChAT ( Smith

- 49 et al, 19 67 ; Allen et al, 1970 ; Cavallit o et al, 19 69 ; Goldbeerg
et al, 1971; :Jak er and Gibson, 1971; 1972 ; Krell and Goldber g , 1975 ) .
Repeatjd att empt s by several i n vestigators to adoi n ist er 4- 1::-v-::t in
vivo and re du c e t he level of bra.in Ach have been unsuccessful ( Carson et al, 1972 ; Glick et al, 1973 ; 2aubric h et al, 1974; Kr ell
and Goldb erg , 19 75).

_Terve ending ChAT activity can be inhi bited

approximately 65% without affecting brain levels of Ach after an i . p .
dose of 200 or 400mg/kg 4- J VP (Krell and Go ldberg, 1975), in dicating
t hat brain ChAT activity is not rate limiting .

An alternativ e

po s s ibility is that t he majority of brain Ach maybe synthe siz ed by
ChAT in a subcellular location inaccessible to the inhibitor .

TO

test this possibility, t h e solubilized and membrane bound f orm s of
the enzym e were incubated in the prescence of varying concentrations
of 4- NV:F and their activities determined.

Th e r esultsrx shown i n

Table 6 indicate that the solub le form of Ch-AT is more sensitive
to inhibition by 4- _JVP than the membrane bound for m of t h e enzyme.
4- NVP , at a concentration of 1. 2ul'"1 , inhibits t he activity of t h e
solubilized enzyme by 65% wit h out significantly reducing t he activity
of the membrane bound for m.

In agreement with Krell and Goldberg

(1975) , the Ki of 4- NVP for the solubilized enzyme was found to be
1 . OuM.

To determine if one or both enzyme forms were inhibited in vivo,
mice were pretreated with either an i . p . injections of 4 - NVP
(200 mg/kg) or saline in equal volumes and t h en killed alternatively
30 minutes later .

Bot h solub ilized and membrane bound enzyme forms

were prepared from both treated and control groups, and their respec tive enzyme activities determined in the prescence of a saturatin g
choline concentration .

Th e results s h own in Tab le 7 indicate t hat

i . p . administration of 200 mg/kg 4- NVP inhibits the activity of the
soluble , cy toplasmic form of Ch-AT by 77% while ne-@ s i .1'i'?lca__ bl:y
0

- 50inhibiting the membrane bound form by only

29,~ .

In the study of Krell and Goldberg (1975), it was reported
that mice injected with

4 -~

VP appeared ataxic and depressed .

behavioral effect was observed in the present

stud~ .

Thi s

The effect

was correlated to the locomotor activity of the mice in Fi g . 3.
In this experiment , 4 mice were injected with 4- NVP (200

~g /kg)

or saline in equal volumes, or not injected, the latter group serving as an injection control.

It was found that locomotor activities

were rduced by approximately 80-90% with respect to either the
injected or noninjected control group, and this decrease in locomot or activity was present 3 hours after a single injection.
Extra.cellular choline is transported into synaptosomes (Ya ma.mura. and Synder, 1972; 1973; Kuhar et al, 1973; 3arker and

~·: i ttag

,

1975; Carr oll and 3uterbaugh , 1975) and brain tissue minces (Carroll
and Goldb erg , 1975) by two distinct upt ake mechanisms , a hi gh
affinity uptake sy stem with a Kt of 0 . 5 to 5 . 0uM and a low affinity
system with a Kt of 50 to 1OOuiVi .

r•:ost of the ch oline transported

into synaptoso:ne s b y hi gh affin ity transport is converted to Ach ,
when an AchE inhibitor is present in t he in cubation (Yamamura and
Synder, 1972 ; 1973 ; Guyenet et al, 1973; Kuhar et al , 1973; Barker
and Mi tta.g , 1975).
The Km values reported for solubilized ChAT with respect to
cho line range from 0 .1 to 0.7m.1 (see Table 8 ).

All reported Km

values ex ceed the hi gh affinity cholinE transport Kt by at least
100 fold .

To determine if the Km for

~embrane

bound ChAT fo r

ch oline might approximate that of high affinity cho line transport ,
t he choline Kineti cs of both solubilized and membran e bound enzyme
forms were deteroined over a ch oline concentrati on of 4 , 25 x10- 3M
to 4 . 25x10- 7i·,I . The results s hown i n :?ig . 4 sugge st that membrane
b ound ChAT appears to have both a high affin ijr,y ( Km=3. 2u ,1 and a low

- 51 affinity ( I~= O . 4 78mF ) Michaelis constant, wher eas the solubilized
form shows only a low affinity Km ( Km=0. 166mI·I ) for cho line (se e
Fig . 5). Hoever , t he prnduction of acetylated endogenous stores
in the

mRmJJXEIR

washed crude

vesic~lar

fraction has been shown to

be approximately 14% of the amount of Ach produced when saturating
choline leve£s are present (see Table 9).

~his

lev el of production

is simi lar tdl that determined when the membrane bound enzyme form
is incubated in the prescence of 4 . 25x10 - 6 ·I or 4. 25x10- 5M choline.
The results shown in Table 10 indicate that the acetylated product
present after incubation of t he membrane bound enzyme form in the
abscence of added choline is actually two moiwties, one with an
Rf value similar to that found for acetylcarnitine .

~ owever,

it

is b-eleived that carnitine is a poor substrate for brainChAT .K( :Bradshaw and Hemsworth, 1972).
The substate specificity of ChAT has been studied by several
investigators and recently , in cat superior cervical ganglion and
rat brain synaptosomes, the choline analogues triethylcholine (TEC)
and homocholine have been shown to be acetyla ed (Ilson and Collier ,
1975; Co lli er et al, 1977; Ilson et al, 1977).

xTherefore, the

abmlity of the membrane bound form of ChAT to a cetylate these analogues was tested 9see Figs. 6 and 7).

In this study, both solubi-

lized and membrane b ound forms of ChAT weEw incubated at varying
time intervals i n the prescence of 4 .25x1o- 2r.1 TEC and 1.0x10- 2L
hom och oline.

Und er these conditions, it was sugge sted that TEC

was acetylated by the membrane bound form of ChAT at 5 ,1 5j 30, and
60 minutes of incubationJCxxhxzmNixa:s:iq:x linearly , w::iereas homocholine was also apparently acetylated by t h e mwmo rane bound form
at 5 , 15 , 30 , and 60 mi nute s of i ncubation .

In contrast, t h e solu-

b ilized enz yme form was less ab le to a.cetylate r:'.:1EC tnan t h e memb rane bound form , and h omoch oline was not acetyla.ted by the solu-

- 52-

b ilized enzyme at 30 minutes of i n cubation, even in the prescence
of a 5 fold excess of the solubilized enzyme for m

~data

not s h own).

The identification of these acetylate d ch oline analogue s was
performe on descending paper chromatography , and Rf values wer e obtainEd (see Table 10).
duct(s)

The se results i mpl y t hat t he acetylated pro-

for med fro o bot h TEC and h omoch oline incubations are dif-

ferent from the value reported for Ach , but their iden±tities

with

respect to the acetylated product(s) obtained durin g incubations
performed in the abscence of choline are less clea.E.
R.f

In f a ct, the

values reported for acetylated TEC and homocholine , which agree

with those reported by Ilson et al (1 977 ) and Collier et al, (1977),
are similar to a .Rf value obtained after incubation in the abscence
of added choline.

Therefore , the identification of the acetylated

ch oline analogues TEC and homocholine by mouse brain membrane bound
ChAT remains unconfirmed.

DISCUSSIO J
Theenzyme that synthesizes Ach , ChAT, is localized in cholinergic nerve terminals, and the majority of the enzyme is bel eived
to be soluble, and Ach synthesis is beleived to occur in t he cytoplasm of the nerve ending ( Fonnurn , 1967; 1968; 1975).

?allowing

cytoplasmic synthesis , A.ch is then beleived to be transj~~~~i into
synaptic vesicles atEEXl!!xlti:ff:m:s::i::»xxi'.Rx11d::z( Fonnum , 1975).

~ owever,

the transfer of Ach into synaptic vesicles above diffusmon levels
has not been demonstrated (Katz et al, 1973; Suszkiw , 197 6).
Additionally, the vesicular emptying of Ach appears to facilitate
the transport of extracellular choline but not Ach into vesicles
independently of the cytoplasm, suggesting that maintenance of
vesicular stores may not be dependent on cytoplasmic synthesis and
transfer of Ach into vesicles (Carroll and Nels on, 1978).

-53Enzyme forms with different surface charges ( Fonnum and
Sore~sson,

~.C al the-

1972) , t ypes of antibodies produced (Singh et al, 1975)

and Ach inhibition characteristics (3ingh et al, 1975) from the
same enzyme source .

~urthermore,

the cytochemical studies of

Feigenson and Barrnett (1977), Bene and Barrnett (1978) and Eattori
et al (1976) have indicated that at least some of the nerve ending
ChAT is associated with vesicular membranes .
Results obtained in this investigatio indicate that a membrane
bound form of ChAT can synthesize Ach , and has properties beleived
to be characteristic of enzymes on membranes, including altered
enzyme kinetics , inhibition susceptibilities , and substrate specificities, than the enzyme off t h e membraBe ( 2 och stadt abd Quinlan ,

1975) .

Other results obtainefilnthis study sugg est t hat some of

the mem'clrane b ound ChAT is located in a position which allows some
Ach to b e s ynth esized and protected from Ac hE hydroly sis and allows
some ChAT to b e active in the prescence of hi gh exog enou s Ac h concentrations .
4- TVP is a reversible , specific inhibitor of solubilized ChAT
(Smith et al , 1967; Cavallito et al , 1969 ; Goldberg et al , 1971 ;
Kre:;. l and Goldberg , 1975) .

In the present experirients, 4- NV? in-

hibited the solubilized form of ChAT to a greater extent than membrane

bou.~d

ChAT mn both invitro and in vivo studies .

It has beensuggested that brain ChAT is present in excess and
is not rate limiting , since a 65;b inhibition of synaptosomal Cl'i..AT
1

can be inhibited by 4- NV? with no effect on brain Ach levels ( Krell
and Goldberg , 1975) and

4-~ VP

has no effect on ch olinergic trans-

mission (Aquilonius et al , 1970).

Another interpretation ms that

solubilized ChAT may be present in a location susceutible to4- JVP ,
whereas memvrane bom1d ChAT is relatively inaccessible to 4- NVP
inhibtion , and may maintain vesicular Ach stores .

Furthermore ,

- 54 Barker (1973) has s hown that 4- ) VP tr eat ment i nhi b it s t he l ow
affin ity uptake of choline, which is not be l eived to be responsible
for providing ch oline for acety lation and Ach production, and has
only a. negli ble effect on hi gh affinity choline uptake , which is
beleived to provide cholin e almost exclusively for Ach synthes is
(se e Freeman and Jenden, 197 6 ) .
The regulation of ChAT by Ach product inhibition has been sugge sted by several investigators ( Pott:er et al, 1968 ; Kaita and
Goldberg, 1969 ; Glover and Potter , 1971), but it is only able to
i nhib it synaptosomal ChAT by 50% at Ach conc entrations of 100mM or
more.

Therefore, for Ach to act as ac physiological inhibitor of

ChAT, the enzyme must be exposed to higher concentrations than are
beleived to be present in the nerve terminal cy toplasm .

On t h e

ot h er hand , the intra.vesicular concentra.tion:mofAch has be:en estimated to be at lea.st 200m ·I (3arkeret al , 1970) .

It has been reported

t hat one form of ChAT ia able to be inhibited by phsyiological
concentrations of Ach , whereas a low

axx:D!:±~

activity form of

ChAT (analogous to the membrane bound form of ChAT) is not profoundly
inhibited by those levels of Ach .

7lri:ExixxR~±±g(Sin gh

et al, 1975) .

This investigation indicates that the membrane bound form of ChAT
may reach maximal inhibition at an extra.vesicular concentration of
150rnrfi , while the solubilized form of ChAT can be completely inh i bited by Acg .
It has b een proposed t hat high affinity choline uptake regulates Ach synthe sis ( Macintosh an d Collier, 1976 ; ?-aubric h and Chi ppendale, 1977).

:Sarker and

r-~ ittag

(1975) and Lefresne et al (1973)

have propsed t hat high affinit y ch oline transport and Ach synthesis
are coupled :proc esses .
Comp ound

( T ~·"?YA

:

Eowever , :.Sarker (1978) has found t hat a

~-J , ~' , ~ -tri me t hyl -_, - pr o pylnyl -a.mm oni um )

can be ta.ken

up bJ the r_ i gh a.ff ini t y tran sport sy stem and not be a c etyla.t ed , and

- 55JLope and Jenden (1 977 ) have found t hat condi t ions wh ic h cor:ipromise
the availability of acetyl CoA lead to a drop in Ach syntnesis without i mpairing high affinity uptake.

I n this investi gation, it was

found t hat t h e degree of inhibition of the membran e bound for m
of ChAT by a lower ed sodium concentration corresponds well wit h t h e
degree of sodium dependency ascribed to t h e hi gh affinity ch oline
transport system in synaptosomes ( Si mon and Kuhar, 197 6 ), suggesting
that the sodium requirement of t he membrane bound form of
MEXXR%a±ENx±~x±kEXXMN±xm

Ch-~T

ma~

in the prescence of a saturating acetyl

CoA concentration may be related to t he sodium reqiurement of the
high affinity c holine transport system.
The choline kinetics determinations on the enzyme forms, done
without correction for endogenous acetylation, indicate t hat the
membrane bound enzyme might have a high affinity component for
choline

( Km=@.IX~DQM 3.2u~. )

similar to the Kt values repotted for

hi gh affinity cholin:e transport.

However, after correction for

endogenous choline acetylation is performed, the choline Michaelis
constants obtained for both solubilized and membrane bound ChAT
are similar ( Km=0.1 67m •1 and 0.478mM , respectively), a result which
a grees with that reported by Kucenski et al (1975).
Recently, it has been discovered that triethylcholine and
homocholine can be acetylated by the cat superior cervical gangl ion
during electrical stimulation to a greater extent than by in vitro
tests, which use solubilized ChAT preparations ( Hemsworth and Smith,
1970; Currie and Mautner, 1974; Ilson and Collier , 1975; Collier
et al, 1977; Ilson et al, 1977).

Furthermore , it has been found

t hat homocholine can be acetylated by a synaptosoma.lx preparation
of rat brain ChAT after a 5 minute incubation (Collier et al, 1977),
and that, while homocholine can be transported by the high affinity
uptake system, not all the homocholine transported during (Collier

- 56et al , 1977) or subsequent to stimulation (Carroll a.'1.d Telson,
1979) is acetylated.

These latter ressults may suggest that

acetylation rather than high affinity uptake is rate limiting.
In this investigation, it was foJmd that triethylcholine
could be acetylated by both the solubilized and membrane bound
Z~ ChAT at a concentration of 4.25x10- 2M, incubated for 30 minutes at 39 C.

The Rf value obtained for the acetylated product

on descending pa.per chromatography correspond to t hat value obtained

£Mxx±xRxX~R±~ia±E«

by Ilson et al (1977).

? owever, t h e

apparent acetylation of homoch oline by membrane bound ChAT appears to b e similar to endog enous acetyla±ion at 60 minutes of
incubation, but not at 5 or 15 minutes .

Furth ermore , the acet yl-

ated compound(s) present after incubation in the abscence of added
C!choline for 60 minutes have identical :tf values , agreeing with
those reported by Collier et al (1977) for acetylated homo choline .
In conc l u sion, it appears that some nerve ending ChAT present
in hypo- osmotically shocked synaptosomes is not solubilized by
high ionic strength washes, and may be nonionically a.ssocd:ated
with syna.ptosoma.l membranes , including vesicula± membranes .

This

membrane bound form of ChAT possess a similar affinity for its
substrate choline as the solubilized enzyme, but OiiD.ly after the
former is corrected for endogenous acetylation.
membra.~e

~F

Furthermore ,

bound ChAT is less sensitive to inhibition caused by 4-

:NVP , Ach , reduced sodium levels, and hydrolysis os Ach formed than
the solubilized form of mouse brain

ChA~ .

TABLE 1

Reported Km values for brain choline- o- acetyltransferase (C hAT)
Tissue source
rat brain

K

(choline)

184w1

KTH (acety lCoA)
13 . 0uM

Kucenski et al
( ! (&%

human put amen

510uM

11. OUl!i

( 1975)
White and Wu ,
(1973)

human caudate

600uM

6. 6uM

II

rat brain
rabbit brain
bovine striatum

410uM
640uM
750uM

18 . 0uJ\'T
11 . Ow 'I
10 . 0uM

11

bovine caudate

800uM

16.0uM

mouse brain

700uM

17 , 0uM

1!

~lover

and Potter ,
(1971)
.v'hi te and Cavall i to ,
(1970)
Kaita ana Goldberg ,
(1969)

TABLE 2

The Recovery and Distribution of Synaptosoaal Choline-O-Acetyl-

tra.nsferase CchAT) and Protein
Sub9ellul'* Fr&ction

ChAT Activit:t*

Protein**

S; (cytoplasaie Ach and

1.01% (2)

J.5% (4)

100mPJ sodium phosphate
buffer wash (solubil1zed ChAT)

67.81% (2)

11..5 (4)

Washed ~'a (meabrane bound
ChATJ

15.~

(2)

SJ.4 (4)

84.42% (2)

99.9% (4)

ChAT not ionicall;y mmd:
bound to membranes
af'ter hype-osaotic
shock)

P2 (total synaptosomal
ChAT J«••••tKlx recovered, and protein)

*CbAT

activities were deterllined as pa Ach/ ag wet wt./ 15',
and the fractions were incub&.ted in the prescenee of a saturating choline concentration (4.25mM).

**Protein
(

was determined by the method of Lowery et al, . (1951).

) indicates nuaber of brains used.

TA3LE 3
Inhibition of Solublil.lized a..nd :·: embrane 'D ound Choline0- Acety ltransf erase (C hAT ) by Acetylcho line (Ach) ~ n = 6 ) .
Enzyme Activity
(pm Ach/ug prot . /15 m in~
C6 of control for 15 min .
inc ubation)
A c h ~ mn l

0 (control )
10
56
100
150
200
~8~

Solubilized ChAT
100±_4 . 4
94 . 5 +17.1
112.1±,13.7
69 . 7±_7 . 3*
39 . 3±_6 . 1*
25 . 1±. ~ .~ *
nondectable

n,.1embrane :B ound ChAT
100±_6.5
116 . 2±,9 . 8
77 . 7+8 . 7
52 . 8±_4 . 3*
31 . O+ ~. 1
30 . 4±:3 . 9*
~-

*

26 . 7±_3. 6*

Enzyme forms were prepared fro m mouse brain minces incubated in 35mMK+Krebs me dium forx 4 minutes at 37 C.
The inhibitory concentrations of Ach are exclusively
extravesicular.

*Results

si gnificantly dmffer f rom control (p

0.05)

TABLE 4
Determination of Choline= O- Acetyltransferase (6hAT)
Activity in Subcellula± "E'ractions of Mouse "E'orebrain
in the Prescence and Abscence of an Excess of Acety lcholinesterase (AchE)

Control *
AcgE**

* ChAT
*-:+

(n=7).

Subcellular Fractions
100mM Sodium
Phosphate
Buff er Wash
','la.s hed P
of P
3
3
129.8 + 20.6
3.9 + 0 . 4
1.6 + o.~
3.9 :!:. 2.6
activity expressed as pm Ach/ug prot./5 min.

Enough Eel AchE was added to the incubation medium
to hydrolyze 2.84umoles of Ach to choline per min .
This amount represents an excess of at least 100,000
fold.

TA3LE 5
The Effect of Lowered Sodium ion concentration on
Choline- 0-Acetyltransferase (8hAT) in Subcellular
Fractions of Mouse 3rain
ChAT Activity (pm Ach/ mg wet wt/5 min
Subcellular Fraction
washed P

3

pooled 100mM
sodium phosphate
buff er washes

* Resmlts

318mM J a+
(Conj;rol)

23 6.3rnM _Ja+
(Lowered }Ja +)

89 . 8 + 8 .7 (5)

34 . 35 + 4 . 9 (5)*

180.1 + 25 .5 (5)

not detectable (5) *

significantly differ from contrilil (p 0 .05)

TA1:3LS 6

In vitro Inhibition of Solubilized and ·1 embra.ne Bound
?orms of Choline- 0- Acetylttansferase (ChAT) by 4- (1naphthyl vinyl ) pyridine ( 4- !JVJ? )

(n =7).

Enzyme Activity
(pm Ach/ ug prot . / 5 min)
4 - l~ VP

(uM)

Solubilized Ch_A.T

Membrane 3 ound ChA'.!'

0 (control)

88 . 0+16 . 8

7 . 56:t,0 . 43

0 . 072

74 . 2:t, 12. 08

7 . 69:t,0 . 41

0.290

70 . 3:t,12 . 0

7 . 34+0.4 6

1. 16

32 . 2:t,7 . 8 *

6. 94:t,0 . 34

4 . 63

12 . 4+6 .1 *

5 . 29+ o.~J

*Results

~*

significantly different from control (p

0 .05) .

TA: LE 7

In vivo Inhibition. of solub iliz ed and Il emb r ane :::: ound
Forms of Ch oline- 0- Acety ltransferas e (ChAT ) by 4- (1 naphthyl vin: 1 )pyridine ( 4- TTV? )
Enzyme Activity
( pm Ach/ ug prot . / 5 oin . )
( ~~ of c ontrol for 5 min
incubat ion)
Treatment *

Solubilized ChAT
100+ 10 (7 )
*.>t.
23±_ 10 (8)

Control
4 - -~ VP

*Mice

I( embrane Bound C.fu.A_
100:t,19

(7)

71 ±_ 7 ~"* (8 )

wer e inje cted with 200mg I kg 4- WVP i . p . or an equal

volume of saline 30 minutes prior to cervical dislocation .
Enzyme forms were prepared from mouse bra.in mi nce s incub ated in 35mI·'1:K+Krebs mediu.m .

( ) i n di cates the number of

br ains used .

** Results

significantly dif ferent from control

(p 0 . 05)

:'ABLE 8

Comparison of Membrane Bound Enzyme Activities in
the Prescence of Various Choline Concentrations (n=82..:_
choline (..1 olar)
4 ,25x10- 3

I embrane Bound ChA:' Azti vi ty
(pm Ach/ ug prot ./1 5 min .)

4 .25x10-?

7.84.:t,0.4 *

0 (no added choline)

9.35.:t,0.5

*Result

significantly lower than value obtained in
the abscence of added choline . (p 0.05)

1 3LE 9

Apparent Rf values of the acety lated products obtained
by pa.per chromatography with various sub strat e s from
filOuse brain minces
Substrate

R

value of acety lated
synthesized by
t h e subcellular fraction
Ht question

fomp ound

1OOmf'!

sodium
phosphate
buff er
wash

was h ed
0 . 30
0 . 90 *

:?

3
o.3o
choline (4 . 25mIV; )
tri ethylcholine ( 42 . 5mM!)
0 . 92 *
a.so **
homocholine (10 . 0mM)
0.74 **
no added substrate
0 . 30& 0 . 74
0 . 30 & 0.80
Descending paper chromatography was performed on
Whatma.n No. 1 paper in a solvent system of n- butanolacetic acid- water (8 : 2 : 3:1).

Incubations were done

at room temperature for 8 hours .
* Rf values agree with those of Ilson et a.l (1977).
** Rf values agree with those of Collier et al (1977) .

Fig. 1

Subcellular FractinatiDn and Enz)'lle Preparation
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Fig. 2

Aoetylation of Choline by Membrane Bound and Solubilized. Forms of ChAT ( O and
.fa , respectively) over tille. Enzyme activities expressed. as pm Ach/ug prot./time
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